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Pilot validation of the Tuberous Sclerosis Associated 





Background: Tuberous Sclerosis Complex (TSC) is a multi-system 
disorder that includes a range of neuropsychiatric manifestations. The 
majority of individuals with TSC will have neuropsychiatric problems, with 
lifetime prevalence rates in the region of 90%. Survey results unfortunately 
suggest a vast gap between need and actual assessment/treatment. At 
the 2012 International TSC Consensus Conference the Neuropsychiatry 
panel coined the term TAND (TSC-Associated Neuropsychiatric 
Disorders) and recommended that all individuals with TSC should be 
screened for TAND at least annually. To aid in the systematic enquiry of 
the behavioural, psychiatric, intellectual, neuropsychological, academic 
and psycho-social difficulties experienced by individuals with TSC, a 
'TAND Checklist' was developed to act as an 'aide-mémoire' to clinicians. 
Here we performed a pilot validation of the TAND Checklist. 
 
Method: Mixed-methods were used across three stages in the pilot 
validation of the TAND Checklist. In stage 1 we gathered feedback on the 
Checklist from 16 international TSC experts and 42 parents/carers. The 
aim was to examine face and content validity. Stage 2 involved the 
administration of the refined TAND Checklist to 20 South African parents 
of individuals with TSC concurrently with four other validated assessment 
tools. The aim of this stage was to examine concurrent validity and to 
obtain qualitative feedback on face-to-face administration of the TAND 
Checklist. Stage 3 involved the collection of demographic and clinical data 
about the individuals with TSC evaluated in Stage 2.  
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Results: Expert clinicians as well as families rated the TAND Checklist to 
have good face and content validity as reflected in quantitative analysis 
which showed high overall mean and median scores of 4 and 5 (five being 
the maximum rating). Interestingly, face to face administration was 
associated with significant higher ratings for ‘clarity’ (P = 0.003) supporting 
advantages of face-to-face administration of the Checklist. Qualitative 
analysis highlighted some concerns about the likely use of the TAND 
Checklist, in particular suggesting that family members of individuals with 
TSC should drive its usage. Stage 2 results showed moderate to very 
good external validity across the behaviour domain, social-communication 
subdomain, hyperactivity subdomain, intellectual ability, 
neuropsychological domain and executive subdomain. Limited validation 
was performed around scholastic skills, and the psycho-social domain did 
not show very robust correlation with external instruments used.  The 
TAND Checklist clinician impact score correlated very well with the impact 
score generated by the SDQ. Internal consistency of domains and 
subdomains was acceptable to very good. Stage 3 demographic data 
suggested that only 25% of the study population had received any tertiary 
education, and that 50% of the sample earned <R3,000 (~$300/£250) per 
month. 
 
Conclusion: Pilot validation of the TAND Checklist supported face and 
content validity, and showed good external validity. Findings suggest that 
this simple, pen-and-paper tool may be a quick (about 10 minutes) and 
helpful aide-mémoire in the identification and subsequent treatment of 
TAND even when administered by a non-clinician with relatively little 
expertise in TSC. Results of other aspects of validity and qualitative 
feedback were used to shape the Checklist to be both clinically meaningful 
and a useful research tool for future studies. 
 
Keywords: TSC, TAND. 
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Chapter 1  Tuberous Sclerosis Complex 
 
 
This thesis will outline the pilot validation of the Tuberous Sclerosis Complex 
Associated Neuropsychiatric Disorders (TAND) Checklist. Chapter 1 will provide 
background information on Tuberous Sclerosis Complex (TSC), its genetic 
origins, diagnostic criteria, physical manifestations and a literature review of the 
neuropsychiatric manifestations. Next it will look at TAND and the TAND 
Checklist. Chapter 2 will discuss the methodology used across 3 stages and 
results will be presented in Chapter 3.  Chapter 4 will present a discussion of the 
results from the pilot validation of the Checklist and Chapter 5 will draw together 





Tuberous sclerosis complex (TSC) is a genetic disorder with multi-system 
involvement. TSC can affect virtually any organ system, with some more 
prevalent during infancy and childhood and others more likely to affect 
individuals as adults (Crino et al., 2006; Curatolo et al., 2008). The most 
common manifestations are benign tumours in the heart, kidneys, lungs, skin 
and brain. TSC is also associated with a vast range of neuropsychiatric 
disorders, typically neurodevelopmental, behavioural and psychiatric difficulties. 
 
The disorder is caused by mutations in either of two genes, the TSC1 gene on 
chromosome 9q34 (van Slegtenhorst et al., 1997; Povey et al., 1994) or the 
TSC2 gene on chromosome 16p13.3. (The European Chromosome 16 
Consortium 1993; Povey et al., 1994). The protein products of TSC1 (hamartin) 
and TSC2 (tuberin) regulate and integrate intracellular signalling pathways, 
including the PI3K, AMPK and MAPK pathways (de Vries and Howe, 2007). A 
mutation in either TSC1 or TSC2 may disrupt the TSC1-2 complex, resulting in 
over-activation of mammalian target of rapamycin (mTOR) signalling, which 
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critically regulates cell growth and proliferation (Tee et al., 2002; Kenerson et al., 
2002). The TSC1/2-TOR signalling pathway also regulates various other 
intracellular processes, including protein synthesis, in response to growth factors 
and nutrient availability. The TSC1/2-mTOR proteins act as integrators of a 
range of intracellular signalling pathways and not only TSC but also in various 
other genetic disorders are associated with abnormalities in this signalling 
pathway (de Vries, 2010; Serfontein et al., 2011).  
Serfontein et al. (2010) examined the evolution of the TSC1/2-TOR signalling 
pathway and, using complete genome sequences, found that the present 
pathway was built up from an ancestral one linking growth and energy supply. 
The authors proposed that, after the divergence of the main eukaryote lineages, 
the pathway became more sophisticated in some lineages through the 
incorporation of additional input (such as TSC1-TSC2) and output elements to a 
central core (Serfontein et al., 2010). Further evolutionary explorations showed 
showed that not all model organisms with TSC1 and TSC2 have high similarities 
to the human sequence with regards to structure and functional elements. 
Results suggested that other mammalian proteins rat (Rattus norvegicus) and 
mouse (Mus musculus), share the largest number of residues with human 
proteins, making these generally appropriate as models for human TSC 
(Serfontein et al., 2011).  
  
The birth incidence of TSC is estimated to be 1 in 6,000 (Osborne et al., 1991; 
O’Callaghan et al., 1998; Thiele and Jozwiak, 2010) and appears to have an 
equal male/female distribution. The majority of cases (up to 75%) occur as 
spontaneous mutations and the remaining ~25% are familial and inherited in an 
autosomal dominant fashion (Crino et al., 2006). Among familial cases TSC1 
and TSC2 are equally distributed; the majority of sporadic cases have a TSC2 
gene mutation (Jones et al., 1997). There is significant phenotypic variability in 
the number and severity of physical features of the disorder (Povey et al., 1994). 
It is important to note that most individuals with TSC will have a normal life 
expectancy. Appropriate management and coordination of medical specialist 
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care is crucial across the lifespan of individuals with TSC to limit morbidity and 
mortality in this disease (Krueger et al., 2013). 
 
Lagos and Gomez, based at the Mayo Clinic reported in 1967 the findings from 
a family of 71 individuals (over five generations) affected by TSC. These data 
led to the first set of diagnostic criteria proposed by Gomez. The so-called 
‘Gomez’ criteria were revised in 1979 (Verdecchia et al., 2006). In 1998, the 
National Institutes of Health (NIH) sponsored the first Consensus Conference 
with the aim to develop consensus recommendations for diagnosis (Roach et 
al., 1998) and clinical management of individuals with TSC (Roach et al., 1999). 
The 1998 diagnostic criteria and 1999 monitoring guidelines were used over the 
past 15 years. 
 
The last 15 years have however seen a number of significant advances in 
understanding the pathogenesis and potential treatments of TSC. In the 1990s, 
the TSC1 and TSC2 genes were discovered and a molecular diagnostic test for 
TSC was launched in the early 2000s (The European Chromosome 16 
Consortium 1993; and Van Slegenhorst et al., 1997). In 2001, the Drosophila 
homologues, TSC1 and TSC2, were found to be involved in regulation of cell 
and organ size (Potter et al., 2001; Tapon et al., 2001). This discovery led to two 
areas of additional important progress in 2002, firstly that tuberin (TSC2 gene 
product) was found to be a target of the PI3k/akt signalling pathway (Manning et 
al., 2002) and secondly, the identification that the TSC1 and TSC2 gene 
products worked together in a complex (Tee et al., 2002). This in turn led to 
discovering the critical role of the TSC genes in regulation of the mTOR pathway 
(Kenerson et al., 2002). Thereafter, an mTOR inhibitor, rapamycin, has been 
shown to reduce renal tumours in Eker rats (Kenerson et al., 2005) and mouse 
models (Lee et al., 2005), and to reduce the size of SEGAs (Franz et al., 2006) 
and renal angiomyolipomas in individuals with TSC (Bissler et al., 2008; Davies 
et al., 2008). By the end of the first decade of the 21st century a number of large-
scale clinical trials of mTOR inhibitors were underway for a number of organ 
systems in TSC.  
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Given the key advances in TSC, there was growing interest in convening a 
consensus conference to revisit the diagnostic criteria, and in particular, the 
monitoring and treatment guidelines for the disorder. The second International 
Tuberous Sclerosis Complex Consensus Conference was held in June 2012 in 
Washington DC, and brought together 79 individuals from 14 countries to review 
and reach consensus on diagnostic, surveillance, and management 
recommendations for individuals with TSC (Northrup et al., 2013). Table 1.1 
shows the updated diagnostic criteria for Tuberous Sclerosis Complex. 
Table 1.1 Updated diagnostic criteria for tuberous sclerosis complex 2012  
A. Genetic diagnostic criteria 
 
The identification of either a TSC1 or TSC2 pathogenic mutation in DNA from 
normal tissue is sufficient to make a definite diagnosis of Tuberous Sclerosis 
Complex (TSC). A pathogenic mutation is defined as a mutation that clearly 
inactivates the function of the TSC1 or TSC2 proteins (e.g., out-of-frame indel or 
nonsense mutation), prevents protein synthesis (e.g., large genomic deletion), or 
is a missense mutation whose effect on protein function has been established by 
functional assessment (www.lovd.nl/TSC1, www.lovd/TSC2, and Hoogeveen-
Westerveld et al., 2012 and 2013). Other TSC1 or TSC2 variants whose effect 
on function is less certain do not meet these criteria, and are not sufficient to 
make a definite diagnosis of TSC. Note that 10% to 25% of TSC patients have 
no mutation identified by conventional genetic testing, and a normal result does 
not exclude TSC, or have any effect on the use of clinical diagnostic criteria to 
diagnose TSC.  
B. Clinical diagnostic criteria  
Major features  
1. Hypomelanotic macules (≥3, at least 5-mm diameter)  
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2. Angiofibromas (≥3) or fibrous cephalic plaque 
3. Ungual fibromas (≥2) 
4. Shagreen patch  
5. Multiple retinal hamartomas 
6. Cortical dysplasias* 
7. Subependymal nodules 
8. Subependymal giant cell astrocytoma 
9. Cardiac rhabdomyomatosis 
10. Lymphangioleiomyomatosis (LAM)** 




1. “Confetti” skin lesions 
2. Dental enamel pits (>3) 
3. Intraoral fibromas (≥2) 
4. Retinal achromic patch 
5. Multiple renal cysts 
6. Nonrenal hamartomas 
 
Definite diagnosis: Two major features or one major feature with ≥2 minor 
features 
Possible diagnosis: Either one major feature or ≥2 minor features 
 
* Includes tubers and cerebral white matter radial migration lines 
** A combination of the two major clinical features (LAM and angiomyolipomas) without other features does not meet 
criteria for definite diagnosis 
 
 
A variety of organs are involved in TSC and manifestations can occur at various 
times during an individual’s lifespan. One of the organ systems most commonly 
affected is the brain, with manifestations seen in 90-95% of individuals with 
TSC. The main neuropathological features of TSC are cortical dysplasias (which 
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include cortical tubers and white matter radial migration lines), subependymal 
nodules (SENs), and subependymal giant cell atrocytomas (SEGAs) (Thiele and 
Jozwiak, 2010, Franz et al., 2010). SENs typically occur in the area of the 
foramen of Monro in the lateral wall of the lateral ventricle and usually remain 
static throughout an individual’s lifetime. Yet, in up to one-fifth of individuals with 
TSC progressive growth of a SEN is seen to lead to SEGA. SEGAs typically 
occur within the first 20 years of life (Franz et al., 2010). They generally exceed 
1cm in diameter (but can grow to >10cm), causing hydrocephalus, focal 
neurological deficits, and even death (Goh et al., 2004). These three lesions 
(CT, SEN, SEGA) demonstrate shared histopathological features including 
abnormal cellular morphology, different regional architecture, and excessive 
numbers of astrocytes (Crino et al., 2010). For growing but otherwise 
asymptomatic SEGAs, either surgical resection or medical therapy with mTOR 
inhibitors can be effective treatment options (Krueger et al., 2010; Franz et al., 
2013; Northrup et al., 2013).  
 
Epilepsy is the most common neurological disorder in TSC, affecting 75-90% of 
individuals (Webb et al., 1991; Thiele, 2004; Thiele and Weiner, 2010). Seizure 
onset occurs within the first year of life in a significant proportion of individuals. 
Partial and partial complex seizures are common in TSC, as well as secondarily 
generalised seizures. A third of infants with TSC will develop infantile spasms 
and a proportion will develop Lennox-Gastaut syndrome (LGS), both potentially 
catastrophic epilepsy syndromes (Muzykewics et al., 2006; Thiele and Weiner, 
2010). Anticonvulsant medications are currently used as first-line treatment 
options for seizures. However, up to three-fourths of individuals with TSC who 
have seizures will develop refractory epilepsy not effectively controlled by 
medical therapy (Kwan and Brodie, 2000; Chu-Shore et al., 2009). Epilepsy 
surgery can be an effective therapeutic option, especially for children with TSC 
who have refractory epilepsy (Thiele et al., 2010). Other treatment strategies for 
refractory epilepsy may include ketogenic diet and vagal nerve stimulation. More 
recently, early phase results have suggested that mTOR inhibitors may be an 
anti-epilepsy treatment in TSC. After a promising phase II trial (Krueger et al., 
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2010) there is currently a multi-centre, international trial underway to evaluate 
the efficacy and safety of mTOR inhibitors as adjunctive treatment for partial 
seizures in TSC (ClinicalTrials.gov: NCT01713946 (EXIST-3)).  
 
The second most frequently affected organ system in TSC is the skin, with 
manifestations also seen in 90-95% of individuals with TSC (Darling et al., 
2010). TSC skin lesions have a characteristic appearance and include 
hypomelanotic macules (oval shaped off-white spots also known as “ash leaf 
spots”), facial angiofibromas (small reddish spots or bumps that consist of 
fibrous tissue and blood vessels), ungual fibromas, shagreen patches (firm 
irregular plaque with coalescing papules and nodules) and “confetti” skin lesion 
(small hypopigmented macules) (Northrup et al., 2013; Darling et al., 2010). 
Even though these skin lesions are benign, they may be painful and lead to 
bleeding. They can compromise normal functions of the nasal passage or nails, 
and distorts normal skin structures (Darling et al., 2010).  
 
Ophthalmologic features include retinal hamartomas and are seen in ~50% of 
individuals with TSC (Thiele and Jozwiak, 2010). These lesions have similar 
histologic features to the brain tubers seen in TSC, are generally benign and 
typically do not affect vision (Northrup et al., 2013). 
 
Cardiac rhabdomyomas are the earliest detectable hamartoma, often seen on 
foetal ultrasound or foetal MRI in TSC, and are the only lesions in TSC likely to 
regress with age (Jozwiak and Respondek-Liberska, 2010). These tumours are 
believed to occur in 50% of individuals with TSC and can be associated with 
cardiac arrhythmias including atrial and ventricular arrhythmia and Wolff-
Parkinson-White syndrome (Thiele and Jozwiak 2010; O’Callaghan et al., 1998). 
 
Lymphangioleiomyomatosis (LAM) is the primary pulmonary manifestation of 
TSC and occurs predominantly in females (McCormack and Henske, 2010). 
Cystic pulmonary parenchymal changes consistent with LAM are observed in 
30-40% of female patients with TSC, although these women are frequently 
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asymptomatic (McCormack and Henske, 2010; Northrup et al., 2013). LAM is 
characterised by a proliferation of smooth muscle cells in nodules throughout the 
lung and associated with interstitial expansion of the lung (Northrup et al., 2013).  
 
The kidney is affected in ~80-85% of individuals with TSC across their lifespan 
and include renal cysts and angiomyolipomas (AML) (Thiele and Jozwiak, 
2010). AMLs are benign tumours composed of vascular, smooth muscle, and 
adipose tissue. Hemorrhage from renal AMLs (proportional to size) can cause 
serious issues and lead to need for dialysis, renal transplantation, and 
sometimes mortality in adults with TSC (Bissler and Henske 2010; Patel et al., 
2005; Bissler and Kingswood, 2004)  
 
Currently there is no known cure for Tuberous Sclerosis Complex. However, an 
understanding of the functional relationship between the TSC1-2 complex and 
mTOR has lead to important clinical advances in the use of mTOR inhibitors. 
Everolimus (Votubia®, Afinitor ®) has been licenced by the European Medicines 
Agency (EMA) and Federal Drug Administration (FDA) for the treatment of 
SEGA not amenable to surgery and for angiomyolipomas >3cm. There are 
ongoing studies of mTOR inhibitors for the treatment of various physical 
manifestations of TSC including SEGA, AML, skin, LAM and epilepsy 
(NCT00789828; NCT00790400; Krueger et al., 2013). 
 
 
1.2 The Neuropsychiatry of TSC 
 
A range of behavioural, psychiatric, intellectual, academic, neuropsychological, 
and psycho-social concerns are seen in individuals with TSC. Neuropsychiatric 
manifestations range from developmental disorders such as Autism Spectrum 
Disorders (ASD), Attention Deficit/Hyperactivity Disorder (ADHD) and 
Intellectual Disability (ID), to mood and anxiety, and other psychiatric disorders 
(Gillberg et al., 1994; Smalley et al., 1994; Prather and de Vries, 2004; de Vries, 
2010b). Even though there are a number of key neuropsychiatric disorders 
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associated with TSC at a group-based level, each individual with TSC will 
present with their own unique combination of strengths and weaknesses across 
different neuropsychiatric levels. Table 1.2 summarises the different levels of 
investigation of relevance in the neuropsychiatric study of TSC. 
 
Table 1.2: Different levels of neuropsychiatric investigation 
 
Level of Investigation Assessment 
1. Behavioural Direct observation, parent & carer surveys, rating scale 
measures 
2. Psychiatric DSM-IV/5 (APA, 1994) and/or ICD-10 (WHO, 1993) 
3. Intellectual Standardised measures of both general intelligence and 
adaptive behaviours 
4. Academic / Scholastic Standardised measures of reading, writing, spelling and 
mathematics  
5. Neuropsychological Rating scale measures (as proxies for brain-referenced skills), 
formal neuropsychological tools  
6. Psycho-social Direct observation, parent & carer surveys, self report 
7. Biological Impact of peripheral characteristics of TSC and other medical 
conditions on neuropsychiatric presentation  
 
 
1.2.1 Behavioural Level 
TSC is known to be associated with a range of behavioural difficulties with the 
first comprehensive and systematic surveys conducted by Ann Hunt in the 
1980s  (Raznahan et al., 2006; de Vries et al., 2007; Muzykewicz et al., 2007; 
Pulsifer et al., 2007; Chung et al., 2011). After her early large-scale surveys, 
Hunt, based in Oxford, later joined the Cambridge team of de Vries and Bolton 
(2007) to conduct a postal survey of children and adolescent with TSC. This 
study found that up to 69% of the cohort had social-communication difficulties, 
40-50% demonstrated disruptive behaviours as well as mood related difficulties 
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1.2.1.1 Social Communication 
As per de Vries (2010b), the social communication behaviours seen in TSC 
show a strong correlation with intellectual ability. In the UK postal survey 
conducted by de Vries et al. (2007), 44% (111/250) of participants were reported 
to have poor eye contact, 55% (136/248) had repetitive and ritualistic 
behaviours, and 48% (119/246) had been classified as having an Autism 
Spectrum Disorder. Forty one percent of the group (80/195) were reported to 
have no communicative language, a further 69% (133/194) had 
speech/language delay, and only 23% of the sample (45/194) had normal 
language with no delay. 
Section 1.2.2.1 will focus exclusively on Autism Spectrum Disorders in TSC. 
 
1.2.1.2 Disruptive Behaviours 
The more intellectually impaired individuals with TSC are, the more likely they 
are to have disruptive behaviours. However, individuals with normal intellectual 
ability (IQ>70) also demonstrate high rates of behavioural problems (de Vries et 
al., 2007; de Vries, 2010b). Most notable, difficulties are associated with restless 
and impulsive behaviour , high rates of aggression (13.3 – 58%; Kopp et al., 
2008; de Vries et al., 2007; Hunt, 1997), temper tantrums (57%; de Vries et al., 
2007) and self-injury (10 – 41%; Staley et al., 2008; de Vries et al., 2007; Hunt, 
1997). 
Section 1.2.2.1 will focus exclusively on ADHD in TSC. 
 
1.2.1.3 Sleep 
Research on sleep and TSC has been very limited. Neuroanatomical 
abnormalities, intellectual disability, psychiatric comorbidities, epilepsy and 
seizures, in addition to anticonvulsant medications could all potentially affect the 
development of circadian rhythms and of sleep-wake cycles (van Eeghen et al., 
2011; Hancock et al., 2005). It is therefore not surprising that sleep disturbance 
is one of the most common behavioural problems in children with TSC. These 
can range from night wakings, waking early, and excessive daytime sleeping to 
seizure-related sleep problems (Curatolo et al., 1991; Stores, 1992). In one 
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postal survey of 300 individuals with TSC, carers reported the presence of sleep 
problems in 58% of the children and seizure-related sleep problems in 41% 
(Hunt, 1993). Bruni et al. (1995) performed overnight polysomnography in 10 
children with TSC and ten healthy age-matched controls. Sleep architecture 
abnormalities were observed in 9 of the TSC cases with the TSC group showing 
shorter total sleep time, reduced sleep efficiency, a higher number of 
awakenings and stage transitions, an increased wake after sleep onset and 
decreased REM sleep. In the first study of sleep in adults with TSC, Eeghen et 
al. (2011) confirmed a high prevalence (31% of the cohort) of sleep disorders in 
adults with TSC (n=35) and an association with epilepsy features. 
 
Taken together all possible behavioural difficulties associated with TSC, 60-70% 
of children with TSC as well as intellectual impairment are likely to present with 
one or more behavioural difficulty, and 20-30% of children with TSC with normal 
intellectual ability may have such behavioural difficulties (de Vries et al., 2007; 
Prather and de Vries, 2004). 
 
1.2.2 Psychiatric Level 
Estimates of psychiatric comorbidity in individuals with TSC have been highly 
variable. This is likely due to different populations studied, methodological 
differences in how formal psychiatric diagnoses were reached, and a range of 
other sampling or methodological issues. As pointed out by Chung et al. (2011), 
the importance of clinical expertise in diagnosing psychiatric disorders cannot be 
over-emphasized given the inherent difficulty in distinguishing psychiatric illness 
from one another and from other central nervous system (CNS) aspects of TSC. 
However, for clinical research findings to be sufficiently robust and reproducible, 
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1.2.2.1 Developmental Disorders 
Autism Spectrum Disorders (ASD) 
Autism is a developmental disorder characterised by deficits in three main 
domains: reciprocal social interaction (such as poorly modulated eye 
contact, limited facial expressions, and lack of subtle skills in reciprocal 
social interaction), verbal and non-verbal communication (delay or lack of 
communicative language, stereotyped or unusual use of language, and 
limited or poorly integrated gestures), and restricted or repetitive pattern 
of behaviours and interests (such as preoccupation with unusual objects, 
repetitive play, stereotyped hand and finger mannerisms or sensory 
interests). To meet ICD-10 and DSM-IV criteria for an ASD, some of the 
developmental concerns have to be present by the age of 3 years (de 
Vries, 2010; World Health Organisation, 1994; American Psychiatric 
Association, 2000). The diagnostic criteria for ASD has been changed in 
DSM-5 (American Psychiatric Association, 2013). Further discussion of 
these changes are outside the scope of this thesis. 
 
Estimates of prevalence rates of Autism Spectrum Disorders (ASD) in 
individuals with TSC have been reported at much higher rates than 
expected, ranging from 16-61% (see Table 1.3). The general population 
rate for autism spectrum disorders is around 1% (de Vries, 2010b). The 
variability in these rates can be explained by the definition of ASD being 
used (classic autism versus autism spectrum disorders) and the 
methodology employed (clinic based studies versus population based). 
The most comprehensive and detailed population-based study using the 
ADOS and ADI-R showed that 26% of children with TSC across all levels 
of intellectual ability met criteria for classic infantile autism and that about 
50% met criteria for an ASD (Bolton et al., 2002). Other studies using 
rating scale and survey methods have consistently reported rates of ASD 
in the order of 25-50% (Smalley et al., 1992; Hunt, 1993; Hunt and 
Shepherd, 1993; de Vries et al. 2007). Table 1.3 provides a summary of 
all studies conducted on TSC and Autism to date (de Vries et al., 2007; 
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Wong, 2006; Curatolo et al., 2006; Calderon et al., 1994; Smalley et al., 
1992; Riikonen and Simell, 1990).  
 




The overall consensus suggests that about 50% of individuals with TSC 
may meet criteria for an ASD which makes TSC one of the medical 
conditions most commonly associated with autism (de Vries, 2010b). 
There have been a range of hypotheses for the clear-cut 
overrepresentation of ASD in TSC. Many suggested tuber count, 
localisation of cortical tubers, abnormal genetic programme, and/or 
comorbidity with epilepsy and learning impairment (Curatolo et al., 1993; 
Gillberg et al., 1994; Bolton, 1998; Sampson, 2003). De Vries and Howe 
(2007) proposed an alternative molecular hypothesis and suggested that 
disruption of the TSC1-2 signalling cascade in TSC may be sufficient to 
disrupt the neurodevelopmental trajectory and lead to the 
neuropsychiatric manifestations of TSC, including ASD (de Vries and 





M:F Diagnostic Criteria / 
Assessment Tools used 
Hunt & Dennis 1987 90 50 24:22 Hunt & Dennis questionnaire 
Riikonen & Simell 1990 24 17 Not specified Not specified  
Curatolo et al. 1991 23 26 12:11 Hunt & Dennis questionnaire 
Smalley et al. 1992 13 54 5:2 ADI 
Hunt & Shepherd 1993 21 25 3:2 Hunt & Dennis questionnaire 
Gillberg et al. 1994 28 61 7:10 CARS, DSM-III-R, ICD-10 
Calderon et al 1994 27 26 2:5 DSM-III-R, ICD-10 
Webb et al. 1996 131 5 Not specified  Hunt & Dennis questionnaire 
Bolton & Griffiths 1997 18 50 Not specified  ICD-10 
Baker et al. 1998 20 20 3:1 ABC, ADI direct exam 
Gutierrez et al. 1998 28 29 1:1 ADI, ADI-R, ADOS 
Wong 2006 44 16 0.75:1 DSM-IV, ADI-R 
De Vries 2007 246 48 Not specified  Postal survey 
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Howe, 2007; de Vries, 2009; de Vries, 2010a). de Vries postulated that 
the increasing number of single gene disorders associated with ASD 
(FMRP, the fragile X associated gene; TSC1 and TSC2, the tuberous 
sclerosis-associated genes; MECP2, Rett syndrome-associated gene) 
may point to an alternative etiological model of autism where disruption in 
a single gene might be sufficient to disrupt the neurodevelopmental 
trajectory towards ASD (de Vries, 2009).   
 
Attention Deficit Hyperactivity Disorder 
The 2nd developmental disorder very commonly associated with TSC is 
attention deficit hyperactivity disorder (ADHD). Curatolo et al. (2009) 
described ADHD in TSC as a multifactorial neurobiological disorder 
caused by the confluence of many genetic and environmental risk factors. 
Individuals with ADHD present with significant problems of attention (such 
as failure to attend to detail), hyperactivity (being fidgety, restless or 
overactive), and often act impulsively (such as butting into conversations 
or failing to wait their turn). To meet ICD-10 or DSM-IV criteria for ADHD, 
these difficulties should be present before the age of 7, should be out of 
keeping with the child’s overall developmental level, lead to impairment in 
their functional skills, be present for at least 6 months, and should be 
observable in more than a single setting (World Health Organisation, 
1993; and American Psychiatric Association, 2000). A diagnosis of ADHD 
requires comprehensive evaluation including developmental history, 
clinical observation of the child in more than one setting, and 
consideration of other developmental, educational, and social factors (de 
Vries, 2010; Taylor et al., 2004).  
General population rates of ADHD vary significantly and much of this 
variability could be explained by the different methodologies employed by 
researchers. A systematic review and meta-analyses of 102 studies 
comprising 171,756 subjects from around the globe showed that the 
ADHD worldwide-pooled prevalence was 5.29% (Polanczyk et al., 2007). 
In contrast to the general population rate, the prevalence of ADHD in TSC 
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is as high as 50% in all individuals with TSC, and ~30% in those with 
normal IQ (Gillberg et al., 1994; Prather and de Vries, 2004; de Vries et 
al., 2006; Muzykewicz et al., 2007). 
The pathogenesis of ADHD in TSC is still largely unknown. The following 
have been proposed as potential contributors and risk factors that may 
predispose individuals with TSC to an increased risk for ADHD: cortical 
tuber location, number of tubers and ‘load’, epilepsy, comorbidity with 
intellectual disability, comorbidity with autism spectrum disorders, and 
molecular aberration (de Vries and Howe, 2007; D’Agati et al., 2009).  
 
 1.2.2.2 Mood and Anxiety Disorders 
In adults with TSC, high rates of depressed mood and anxiety have been 
shown (Pulsifer et al., 2007; Lewis et al., 2004: Raznahan et al., 2006; de 
Vries et al., 2007; Muzykewicz et al., 2007; de Vries et al., 2010; Chung 
et al., 2011;). Lewis et al. (2004) used a well-standardised diagnostic tool 
to evaluate anxiety and depression in individuals with TSC and showed 
that 56% of their study population met criteria for an anxiety disorder and 
19% for a depressive disorder. Muzykewicz et al. (2007) showed 
increased rates of mood disorders, prevalent in 26% of the study 
population (recurrent, major, dysthymic, and NOS) and a further 28% had 
anxiety disorders (generalised, separation, NOS, panic disorder, 
obsessive-compulsive disorder). The rate of mood and anxiety disorders 
amongst adults with TSC, while often variable, remains consistently high. 
 
1.2.2.3 Other Psychiatric Disorders 
There is very limited information about other psychiatric disorders in TSC, 
but reports include schizophrenia and other psychotic disorders, eating 
disorders, dementias, bipolar affective disorder (a type of mood disorder), 
alcoholism, obsessive compulsive disorder and tic disorder (Sedky et al., 
2003; Goh and Thiele, 2005; Raznahan et al., 2006; Muzykewicz et al., 
2007; de Vries, 2010b; Bhattacharya et al., 2012). The rates of psychotic 
disorders in TSC seem to be around 1-5%, either as a primary or 
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secondary diagnosis (Raznahan et al., 2006; Muzykewicz et al., 2007; de 
Vries, 2010b; Chung et al., 2011). It therefore seems that, in contrast to 
developmental disorders, psychotic disorders are not overrepresented in 
TSC in comparison to the general population where rates are in the order 
of 1% (de Vries, 2010b). Psychotic phenomena in TSC (delusions and 
hallucinations) should therefore always raise the suspicion of seizure-
related abnormalities such as temporal lobe epilepsy that has a clear 
association with psychosis (Lishman, 1997).  
 
1.2.3 Intellectual Disability 
The majority of individuals with TSC (~70%) will have intellectual ability that falls 
on a normal distribution similar to that of the general population except that the 
mean IQ score is shifted downward to 93 versus 100 in the general population 
(Joinsen et al., 2003; de Vriesb, 2010). This means that about 50% of those with 
TSC will have normal intellectual abilities, and a further 20% will have mild, 
moderate or severe intellectual disability (de Vries, 2010b). The remaining 30% 
have profound intellectual disability with IQ equivalents below 20 (Prather and 
de Vries 2004; de Vries 2010b;). In the first systematic study of intellectual and 
neuropsychological skills in TSC, Jambaque et al. (1991) found that 30.5% 
(07/23) had IQ scores in the normal range (between 81 and 119, mean 100), 
eight between 43 and 65, and a further eight had IQs <40. The study was 
however based on a clinical case series, where more mildly affected individuals 
may have been under-represented. In a population-based sample of 108 
individuals with TSC in the Wessex region of the UK, Joinsen et al. (2003) found 
that 55.5% had normal intellectual ability, 14% had mild, moderate or severe 
intellectual disability and 30.5% had profound intellectual disability. Earlier 
population-based studies, such as that estimated in the ascertainment of the 
Wessex population in Webb et al. (1996), showed higher prevalence rates of 
intellectual disability, but did not use any standardised measures to determine 
intellectual level. There are thus two intellectual subgroups or phenotypes in 
TSC, the normal distribution (ND) phenotype and the profound (P) phenotype 
(de Vries and Prather, 2007) representing a bimodal distribution of intelligence in 
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TSC. Humphrey et al. (2004) investigated the level and trajectory of cognitive 
functioning in children between the ages of 11 and 37 months. The Mullen 
scales of early learning (MSEL) (Mullen, 1995) were used to measure cognitive 
functioning at 6-month intervals. Researchers found that children with TSC 
slowly but steadily gained skills in many areas of functioning but also that they 
gradually fell further and further behind. 
 
The majority of studies show that a history of seizures and/or infantile spasms 
correlates with the degree of intellectual impairment (Curatolo et al., 1991; 
Shepherd and Stephenson, 1992; Hunt et al., 1993; Humphrey et al., 2004; 
Jansen et al., 2007;). The largest investigation of intellectual and adaptive 
development in patients with TSC was done by van Eeghen et al. in 2012. This 
longitudinal study identified significant associations with epilepsy characteristics 
and intellectual development, highlighting the need for early interventions in this 
population group. However, in these studies only a small percentage of the 
variance in IQ was explained by epilepsy, and other studies (de Vries, 2002; de 
Vries et al., 2009; Tierney et al., 2011) were unable to show correlation between 
epilepsy and intellectual ability. 
 
The number of tubers has long been suggestive of an increased risk of 
intellectual disability; those with more tubers being at higher risk (Jambaque et 
al., 1991; Shepherd et al., 1995; Goodman et al., 1997; Raznahan et al., 2007). 
However, studies conducted by Inoue et al. (1988), de Vries (2002) and more 
recently by Jansen et al. (2008) could not establish a link between number of 
tubers and cognitive functioning. Overall, some studies have found correlations 
and others were unable to. It is important to note that correlation does not equal 
causation. These findings led de Vries and Howe (2007) to propose the 
molecular model where neither tubers nor seizures were predicted to be 
necessary nor sufficient to explain the intellectual abilities observed in TSC. It is 
however possible that the best overall explanatory models may be combinatorial 
between molecular and other factors, which may include structural and other 
environmental modifiers. 
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Familial studies have shown significant variability and the phenotypic range 
within families with TSC is not well understood. IQ appears to show both 
interfamilial and intrafamilial variation (Gomez et al., 1982; Joinsen et al., 2003; 
Humphrey et al., 2004; Lyczkowski et al., 2007). 
 
1.2.4 Academic or Scholastic Level 
In this subdomain of evaluation, the focus is on scholastic and academic 
performance, referred to as “learning disorders” in the DSM-IV revised 
(American Psychiatric Association, 2000). Children and adolescents with TSC 
are at higher risk of experiencing difficulties with reading, writing, spelling and 
mathematics. To date there has been no systematic studies of the rates and 
types of learning disorders individuals with TSC suffer from. Parental and 
teacher reports however indicate that children with TSC tend to struggle with 
academic skills. In de Vries (2002), a standardised rating scale measure showed 
that 36% of normally intelligent children with TSC were at high risk of learning 
disorders. Both the ICD-10 and DSM-IV postulate that maths disorders are 
common in children who have ADHD or other attention-related difficulties 
(American Psychiatric Association, 2000; World Health Organisation, 1993). 
Given the high rates of ADHD in TSC, this puts individuals with TSC at even 
further risk of experiencing math-related difficulties including linguistic aspects 
(understanding math terms), perceptual math skills (visuospatial aspects), 
attentional skills (copying numbers), or in learning maths facts. Anecdotal 
evidence in TSC suggests that mathematical difficulties are indeed a common 
challenge for many individuals with TSC, but further systematic studies are 
clearly warranted (de Vries, 2010b). 
 
1.2.5 Neuropsychological Deficits 
A range of neuropsychological deficits are seen in TSC and several studies 
have reported difficulties with executive functioning skills, attention skills, 
memory, and language skills (Harrison et al., 1999; de Vries, 2002; de Vries and 
Prather, 2004; Ridler et al., 2007; de Vries et al., 2009; de Vries, 2010b; Tierney 
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et al., 2011;). Suggestions to date suggest that the neuropsychological domain 
most commonly affects is that of executive control processes (de Vries, 2010b).  
 
1.2.5.1 Executive skills 
Executive skills, also referred to as executive control processes, are a 
family of functions that include the regulatory functions (such as response 
inhibition), attentional control functions (such as dual tasking) and goal-
directed functions (such as planning) of the brain (de Vries, 2010b). 
These skills, processed in the cortico-striatal brain structures including 
the prefrontal cortex, enables an individual to develop and execute plans, 
solve problems, adapt to unexpected circumstances, do many tasks 
simultaneously, and obey social rules. Therefore, executive skills provide 
individuals with the strategies and tools needed to successfully navigate 
the world we live in. Studies that investigated the cognitive and 
neuropsychological aspects of children and adults with TSC have 
identified significantly poorer performance on executive skills tasks 
(Harrison et al., 1999; Ridler et al., 2007; de Vries et al., 2009; Tierney et 
al., 2011). Harrison et al. (1999) examined cognitive deficits in 7 adults 
with TSC using 8 standardised assessment tools. The researchers did 
not identify any single executive skills deficit across individuals, but found 
that 70% of participants performed below the 5th percentile on at least 
one task. Apart from inter-individual variability, there is also evidence of 
variability in executive function deficits amongst family members with 
TSC, which further highlights the need for individual assessment 
(Lyczkowski et al., 2007).  
 
1.2.5.2 Attentional Skills 
In 2009, de Vries, Gardiner and Bolton conducted the first systematic 
evaluation of neuropsychological attentional skills in a population-derived 
sample of 20 children with TSC and 17 unaffected siblings. Three 
domains were assessed in this study; general intellectual ability, 
attention-related behaviour, and neuropsychological attention skills. The 
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Test of Everyday Attention for Children (TEA-Ch) was used (Manly et al., 
1999) to assess various components of attention, specifically selective 
attention, sustained attention, attentional switching, and dual tasking. 
Thirty five percent of children with TSC showed impairment (defined as 
performance below the 2nd percentile for age and gender) in the selective 
attention tasks, 50% in the sustained attention tasks, and 75% were 
impaired in dual tasking. The study found that 90% of participants were 
impaired on one or more tasks with no obvious pattern of attention 
deficits. The neuropsychological attention skills of 19 adults with TSC and 
21 matched controls were assessed by Tierney et al. in 2011, using 
identical tasks of the TEA-Ch used by de Vries et al. (2009), in addition to 
the Attention-Deficit Scales for Adults (ADSA), a behavioural rating scale 
for attention deficit behaviours in daily life. In contrast to the findings in 
children and adolescents above, no group differences were found in the 
sustained or selective attention tasks, but the TSC group demonstrated 
significant neuropsychological attention difficulty on the cross modal dual 
task, similarly to the children and adolescents in de Vries et al. (2009). 
The study showed a significant correlation between dual task and 
attentional performance in daily life. For instance, dual task decrements 
(the ‘loss’ of speed and accuracy under dual task conditions) were 
strongly correlated with the subjective perception of feeling easily 
overwhelmed and not being able to deal with competing task demands. 
These findings demonstrated that adults with TSC, similar to the 
performance of children with TSC (de Vries et al., 2009), have particular 
difficulty in dividing attentional resources between two tasks in daily life. 
Together, results suggested that children and adults with TSC are at a 
significantly increased risk of neuropsychological attention deficits that 
may have a direct impact on their living skills.  
 
1.2.5.3 Memory skills 
In the first study to explore neuropsychological skills in TSC, Jambaque 
et al. (1991) studied the intellectual and neuropsychological skills of 23 
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children with TSC aged 3-16 and found that 30% (7/23) had memory 
impairments. Much later in 2007, Ridler and colleagues examined 25 
adults with TSC and 25 controls on a battery of neuropsychological tools 
(including the Cambridge Neuropsychological Test Automated Battery, 
CANTAB) with a primary focus on memory skills. Results showed that 
adults with TSC had significant deficits on tests of long-term memory, 
especially immediate recall rather than recognition and on tests of 
working memory (verbal and spatial). There have not been many studies 
examining memory skills in individuals with TSC, but it is clear from Ridler 
et al. (2007) that there are definitive group differences when comparing 
memory skills of individuals with TSC with those of a control group. 
Future research should focus on memory skills in family members with 
TSC, in children with TSC, and their developmental trajectory. 
 
1.2.5.4 Language skills 
Apart from indirect evaluation there have been no studies with a primary 
focus on language skills in TSC, to our knowledge. We do however know 
from indirect examination during research performed on other 
neuropsychological domains that individuals with TSC seem to have 
language difficulties (Jambaque et al., 1991; Prather et al., 2006; and 
survey evaluation done by de Vries et al., 2007). In a significant 
proportion of individuals with TSC language delays may be associated 
with autism spectrum disorders. However, findings from e.g. de Vries et 
al. (2007) seem to suggest that even in individuals without ASD, 
language and language development may be compromised.  
 
1.2.6 Psychosocial Level 
At this level it is important to note that many psychological and social aspects 
may impact on the wellbeing of the individual with TSC and on their ability to 
function successfully within the family and society as a whole. Having a family 
member with a complex physical and developmental disability such as TSC can 
have a significant impact on family stress (Whittemore and Lewis, 2010; de 
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Vries, 2010b). Maladaptive family behaviour such as “over-caring”, parental 
withdrawal, and denial of the severity of problems can hinder the individual with 
TSC’s journey towards acceptance, empowerment, and adaptive behavioural 
strategies (de Vries, 2010b).  In order to understand how an individual 
experiences his illness and copes with it requires knowledge of what the disease 
means to the individual. Psychosocial factors influence the trajectory and 
outcome of every illness, therefore it is imperative that their evaluation should 
form a part of medical diagnosis and management (Lipowsky, 1969). 
 
1.2.7 Biological 
As discussed earlier in the chapter, TSC involves multiple organ systems and 
any neuropsychiatric manifestations should be seen within the context of other 
physical problems. As suggested by de Vries 2010b, a change in one or more of 
the neurocognitive or neurobehavioural levels of investigation may be an 
indication of a physical disorder such as an infection or an electrolyte 
disturbance, may be a manifestation of epilepsy, a side-effect of medication, or 
herald a growing SEGA. 
 
Taken together, the majority of individuals with TSC will have some 
neuropsychiatric problems in their lifetime, with lifetime prevalence rates in the 
region of 90%. There are no obvious ‘natural clusters’ of TAND profiles that 
have been identified to date, and this uniqueness prohibits clinicians from 
predicting a pattern of neuropsychiatric deficits. Research has enabled TSC 
experts to predict what to look for, but not what each individual will present with, 




1.3 TAND (TSC-Associated Neuropsychiatric Disorders) 
 
As outlined above, the 1998 consensus panel generated some basic monitoring 
guidelines for TSC. In an attempt to improve clinical guidelines for cognitive and 
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behavioural problems, an international consensus group were convened in 
Cambridge, UK, funded by the Tuberous Sclerosis Association (UK) and the 
TSAlliance (USA). A panel of 20 clinicians and family members produced 
consensus guidelines for assessment of individuals with TSC (de Vries et al., 
2005). 
 
In 2010, 5 years after the publication of the consensus guidelines (de Vries et 
al., 2005) a survey of members of the Tuberous Sclerosis Association in the UK 
indicated that only 18% of individuals with TSC had ever received an 
assessment or treatment for neuropsychiatric disorders (personal 
communication Prof P.J. de Vries). These results suggested a vast gap between 
need and actual assessment/treatment of around 70%, referred to as a 
‘treatment gap’. At the 2012 International TSC Consensus Conference in 
Washington DC, the neuropsychiatry panel chaired by Prof P.J de Vries, 
expressed concern about the enormous treatment gap and considered how to 
improve basic evaluation and onward referral for more comprehensive 
neuropsychiatric work-up of individuals as required. As a first step, the panel 
decided to coin the term TAND, TSC-Associated Neuropsychiatric Disorders. 
One of the key motivations for coining the term TAND was an attempt to draw 
attention to this important clinical area. An outcome from the consensus panel 
was therefore to recommend that all patients with TSC should be screened for 
TAND at each clinic visit, and at least annually (Krueger et al., 2013). To 
facilitate this process of screening, the Neuropsychiatry panel agreed to 
generate a TAND checklist that can be used as a screening tool by health care 
personnel in any clinical setting. The panel were clear that they did not want to 
develop a ‘diagnostic’ tool that would have the sensitivity and specificity to 
identify specific neuropsychiatric disorders, but rather to develop a screening 
‘Checklist’ to guide healthcare teams in a systematic enquiry of the current 
behavioural, psychiatric, intellectual, academic, neuropsychological and psycho-
social difficulties of the individual with TSC. If any of the above mentioned 
clinical and neuropsychiatric aspects are of concern to the 
parent/carer/individual with TSC, the goal of the TAND Checklist would be to 
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describe some of these areas of need and highlight the need for more 
comprehensive diagnostic workup and treatment. 
 
As outlined above, the neuropsychiatric manifestations of TSC are present at 
multiple levels of investigation from behavioural to psychiatric, 
neuropsychological to educational. Assessment and treatment therefore 
requires multi-agency and multi-disciplinary involvement. Across each of these 
levels of investigation, standardised tools have been generated over the last few 
decades to aid screening, diagnosis and quantification of neuropsychiatric 
manifestations. These include rating scale measures for behaviour such as the 
Strengths and Difficulties Questionnaire (SDQ), the Behaviour Rating Inventory 
for Executive Functions (BRIEF), a simple screening tool for developmental and 
intellectual development (Wessex) and the Social-Communication Questionnaire 
(SCQ) for ASD features (Kushlick et al., 1973; Goodman, 1997; Gioia et al., 
2000; Rutter et al., 2003). In addition, research tools have been developed to aid  
diagnosis of psychiatric disorders such as autism and depressive disorders. 
Tools include the ADI-R (Autism Diagnostic Interview-Revised) (Lord et al., 
1994), ADOS (Autism Diagnostic Observational Survey) (Lord et al., 2000), 
SADS (Schedule for Affective Disorders and Schizophrenia) (Endicott and 
Spitzer, 1978), and numerous others (de Vries, 2010b). Many of these 
psychometric tools and sophisticated neuropsychological assessment tools such 
as Cambridge Neuropsychological Test Automated Battery (CANTAB) are 
excellent in their own right. However, they have significant limitations in terms of 
multi-level neuropsychiatric evaluation as required in TSC. The majority of the 
tools are not routinely available at clinics, and when they are used, tools are 
copyrighted with a charge per use, ranging from a few Dollars to many 
thousands of Dollars.  Many health care providers are not adequately trained to 
use these tools or do not have easy access to clinical psychologists, 
psychometricians or neuropsychologists who could perform and interpret formal 
tests. Importantly, none of the tools capture the different levels of investigation 
required in TSC (behavioural, psychiatric, intellectual, neuropsychological, 
educational and psycho-social) or have been validated across all ages and 
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developmental levels. It would therefore have been extremely complicated to 
assemble a ‘battery of screening tools’ that would allow for screening across all 
the neuropsychiatric dimensions outlined, across age and ability level.  
 
1.3.1. TAND Checklist 
One of the goals of the International Neuropsychiatry Panel was therefore to 
develop a simple TSC Checklist that would be globally and freely available to all 
clinicians and families. Basic criteria for a clinically meaningful tool were 
therefore to be simple to use, free/inexpensive, pen-and-paper based (not 
requiring specialized equipment), and usable by a range of healthcare providers, 
not just highly specialist clinicians. Most importantly, the TAND Checklist should 
be deemed to have face validity (seen by professionals and families as 
capturing the essential and important aspects of concern), content validity 
(judged by experts to cover the range of neuropsychiatric concerns of relevance 
to TSC), and transferability (the ability of the tool to be used across different 
settings by different people). 
 
The International TSC expert panel produced the first version of the TAND 
Checklist in December 2012. The TAND Checklist includes 7 milestone items 
(years, month, and weeks), 3 current functioning items (categorical), 38 
dichotomous (yes/no) questions across behaviour (19 items), as well as 
diagnosis diagnosis (6), scholastic difficulties (4), neuropsychological skills (6) 
and psycho-social functioning (3) items. Finally impact scores (ordinal scale 1-
10) completed by the parents and clinician/researcher were included. As 
mentioned above, the international panel was keen to develop a ‘checklist’ 
rather than a ‘rating scale or questionnaire’. A checklist is a mnemonic device 
that allows for systematic evaluation of a number of features or criteria and is 
specifically aimed at acting as an ‘aide-mémoire’ for the clinician during their 
interaction with the family. Checklists are aimed at reducing errors of omission 
and are generally easier to administer and understand (Scriven, 2000). From a 
practicability point of view, a checklist should be straightforward to administer 
and the individual with TSC and/or their family members should find it easy to 
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understand. From a checklist validation/evaluation point of view, Stufflebeam 
(2000) recommended that a comprehensive checklist evaluation should target a 
minimum set of criteria. He recommended that these criteria included pertinence 
to the content area, comprehensiveness, clarity, applicability to full range of 
intended uses, concreteness, parsimony, ease of use, and fairness. No 
investigations to date have examined the psychometric properties and 
usefulness of the TAND Checklist. 
 
 
1.4 Purpose of the study 
 
In this study we performed the first pilot evaluation of the TAND Checklist with 
the aims to:  
 
1. Refine the TAND Checklist - examine face and content validity of the 
TAND Checklist through expert review 
The purpose of this objective was to look at face and content validity of 
the TAND Checklist to ensure that the areas of neuropsychiatric concern 
in TSC are being covered. Feedback from the cohort was used to refine 
the TAND Checklist and make minor amendments. This analysis also 
explored the perceptions and perceived usefulness of the TAND 
Checklist. 
 
2. Validate the TAND Checklist as a screening tool that identifies and 
quantifies neuropsychiatric manifestations in TSC - examine the external 
validity of the TAND Checklist through face-to-face administration. 
To investigate the external validity of the TAND Checklist by comparing it 
to the findings from other validated assessment and screening tools. 
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3. Demographic data review - determine the demographic characteristics of 
the face-to-face sample. 
Data used for this analysis was extracted from the participants who were 
involved in Stage 2 of the study. The the purpose was to determine 
whether the sample were representative of the population of the Western 
Cape and South Africa as a whole. 
 
We hypothesised that the TAND Checklist would have good face and content 
validity amongst expert TSC clinicians as well as individuals with TSC and their 
families. Furthermore, we predicted that the TAND Checklist would correlate 
well with the four other widely used and validated assessment tools in terms of 
key domain areas being tested i.e. behaviour, psychiatric, intellectual ability, 
academic, neuropsychological, and psycho-social. Lastly, we hypothesised that 
the cohort used may not be representative of the South African general 
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Chapter 2  Methodology 
    
2.1 Study Design 
 





Figure 2.1 Summary flowchart of the pilot study 
Stage 3 
Demographic and clinical data collection 
• Objective 





Expert Group Review 
• Objectives 
– gather feedback to facilitate refinement of Checklist 
– measure content validity & generalisability 
 
• Survey 15 international TSC experts 
– recruited via TSAlliance 
– range of expertise  
 
•	  Survey 55 TSC user/carer representatives from 28 countries 
–Caregivers and Individuals with TSC recruited through TSCi and ATSS 
	  
Stage 2 
Administration of refined TAND Checklist 
• Objectives 
–   measure concurrent validity  
– obtain qualitative feedback on credibility 
– measure internal consistency 
 
• Parents/carers of 20 individuals with confirmed TSC diagnosis 
- recruited via treating physician 
 
• Administer TAND Checklist to the parents 
 
• TAND Checklist feedback  
	  
•Parents to complete 4 widely used and validated screening tools	  
	  
	   29	  
2.1.1 Stage 1 
In Stage 1 qualitative and quantitative feedback was collected on the draft 
TAND Checklist from two expert groups: 
A) a multidisciplinary panel of international TSC experts (referred to as the 
‘professional expert’ group) and  
B) an international panel of user/carer representatives (referred to as the ‘parent 
expert’ group).  
 
All professional experts were sent either an electronic copy or a paper version of 
the TAND Checklist v.1 (Appendix A) and an Expert Feedback Form (Appendix 
D). They were asked to provide scores and comments on the five questions on 
the Expert Feedback Form.  
 
The Expert Feedback Form consisted of 5 quantitative and open-ended 
qualitative items to capture aspects of comprehensiveness, clarity, ease of use, 
applicability and subsequent validity: 
1. Comprehensiveness: Does the Checklist cover the relevant range of 
neuropsychiatric features you think is important in TSC? Please indicate 
missing items. 
2. Clarity: Are the items clear and understandable? Please indicate unclear 
items and how you would suggest improving them. 
3. Ease of Use: Overall, how easy do you think the Checklist will be to use? 
What might improve ease of use?  
4. Applicability: How likely do you think clinicians are to use the Checklist? 
What could be done to increase the likely use by clinical teams? 
5. Subsequent validity: How likely is the Checklist to encourage clinicians 
to pursue further neuropsychiatric work-up or referral to relevant 
specialists? What can be done to increase the likelihood? 
 
Lastly we examined internal consistency of the TAND Checklist to measure the 
correlations between different items on the same domains and subdomains.  
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2.1.2 Stage 2 
In stage 2 the TAND Checklist v.2, as modified based on feedback from stage 1 
(Appendix B), was administered by the research team to parents/carers of 
individuals with TSC in the Western Cape, South Africa. On completion of the 
TAND Checklist with a researcher, the parents/carers were asked to complete 
the Expert Feedback Form. Thereafter, parents/carers were asked to complete 4 
well-established and widely used rating scale measures (the SDQ, SCQ, BRIEF 
and the Wessex). Further details about these instruments are provided below. 
(Appendices E,F,G & H).  
 
2.1.3 Stage 3 
In stage 3 demographic data about the individuals with TSC whose 
parents/carers participated in Stage 2 of the pilot study were collected from 
parents (Appendix I) in order to examine the characteristics of individuals with 
TSC who participated in the pilot project. Data collected included: 
1. gender and age of individual with TSC 
2. rural or urban living 
3. household income 
4. parental level of education 
5. schooling placement, e.g. special education, private schooling, 
mainstream 
6. current grade level (e.g. what year or grade in school) 
7. clinical manifestations of TSC e.g. tumours and epilepsy 
8. previous or existing neuropsychiatric diagnosis e.g. autism spectrum 
disorder 
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2.2 Research Site 
 
The project was conducted in the Division of Child & Adolescent Psychiatry at 
the University of Cape Town, South Africa. Stage 1 data were collected remotely 
and sent to the research team for processing. Stage 2 data were collected by 
the research team in collaboration with the primary treating clinician at the Red 
Cross War Memorial Children’s Hospital, Cape Town and/or in the Division of 
Child & Adolescent Psychiatry, based on participant preference. Stage 3 data 
were collected from families. 
  
   
2.3 Participants 
 
2.3.1 Stage 1 
‘Professional experts’ (Stage 1A) were recruited in collaboration with the 
TSAlliance to represent wide-ranging areas of expertise relevant to TSC.  The 
research team generated a list of internationally known academics in TSC 
including paediatricians, developmental paediatricians, paediatric neurologists, 
adult neurologists, geneticists, physicians, basic scientists, educationalists, 
psychologists, intellectual disability experts, specialist nurses and social 
workers. Professional experts were invited to participate electronically and were 
provided with the TAND Checklist and Expert Feedback Form, as outlined 
above. The team continued to invite experts until a minimum of n=15 responses 
were received. 
 
‘Parent experts’ (Stage 1B) were recruited through two mechanisms. The first 
group consisted of parents/carers who were participants at an Annual Meeting of 
the ATSS (Australasian Tuberous Sclerosis Society). All parents/carers present 
at the ATSS meeting were invited to contribute to the evaluation of the TAND 
Checklist, but were free not to participate. To ensure a broad international 
representation, a second group of ‘expert parents’ were recruited. An electronic 
copy of the TAND Checklist and Expert Feedback Form was emailed to all 
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national representatives of Tuberous Sclerosis Complex International (TSCi) 
who were asked to provide scores and comments on the Expert Feedback 
Form. All feedback received by 30 September 2013 was included in the study. 
 
2.3.2 Stage 2  
Study participants for stage 2 were recruited through primary clinicians at the 
Red Cross War Memorial Children’s Hospital TSC clinic, and from other UCT-
affiliated hospitals (Groote Schuur, Lentegeur and Alexandra). Potential 
participants had to meet definite criteria for TSC (Roach et al 1998; Krueger et 
al., 2013) and had to have a parent/carer who could complete the research 
questionnaires and interview in English. Participants were not required to speak 
English as a first language, but had to have a sufficient understanding of English 
to allow participation. Potential participating families were provided with 
information sheets and consent forms by the treating clinicians. Families 
interested in participating were then scheduled for face-to-face sessions. The 
team continued to recruit until n= 20 participants were identified. Given that the 
focus of this study was on neuropsychiatric manifestations in individuals with 
TSC across all ages, gender and developmental level, no inclusion criteria other 
than diagnostic status and parental ability to participate in English, were used.  
 
 
2.4 Instruments used 
 
2.4.1 The TAND Checklist, see Appendices A & B.   
A pen-and-paper checklist, developed by the international TSC Neuropsychiatry 
Panel in 2012, to screen for neuropsychiatric manifestations of TSC across 10 
different domains. This is the measure under investigation in this study. 
 
2.4.2 The Strengths and Difficulties Questionnaire (SDQ), see Appendix E. 
The SDQ is a widely-used behavioural screening questionnaire that can be 
completed by the parents and/or teachers of 4-16 year olds. There is also a self-
completion version for 11-17 year olds (Goodman, 1997). The SDQ generates a 
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total difficulty score (out of a maximum of 40) and a pro-social score (out of 
maximum of 10). The total difficulty score consists of 4 domains (hyperactivity, 
emotional, conduct and peer relationships). Goodman (2001) examined a 
nationwide epidemiological sample of 10,438 British 5-15 year olds and reported  
satisfactory reliability across the 5-factor structure, with a mean Cronbach's 
alpha of 0.73 across the 5 domains suggesting good internal consistency of the 
SDQ as a screening tool. Its sensitivity in terms of hyperactivity and conduct 
problem was 68% and 74% respectively for the parent version. The percentage 
for the specificity was 89% for all parent, teacher and youth versions. In this 
study, the 5-factor parent version was used..  
 
2.4.2 The Social-Communication Questionnaire, see Appendix F. 
This is a brief pen-and-paper questionnaire developed by Rutter and colleagues 
(Berument et al., 1999) as a secondary screening tool of the social-
communication and repetitive/stereotyped behaviours of an individual who may 
have an autism spectrum disorder. A cut off score of ≥15 on the SCQ is 
suggestive of ASD and a cut off of 22 suggestive of Autism (Berument et al., 
1999; and Eaves et al., 2006). A score of 15 was reported to have a specificity 
of 0.80 and a sensitivity of 0.96 when differentiating individuals with autism 
spectrum disorders from other diagnoses (not including people with ID) and a 
specificity of 0.67 and sensitivity of 0.96 when differentiating individuals with 
ASD from those with ID. A score of 22 was reported to be associated with a 
specificity of 0.60 and a sensitivity of 0.75 for differentiating individuals with 
autism from other autism spectrum disorders (Rutter et al., 2003). Subsequent 
studies to validate the SCQ also showed strong discrimination between ASD 
and non-ASD cases (sensitivity 0.88; specificity 0.72) and between autism and 
non-autism cases (sensitivity 0.90; specificity 0.86) (Chandler et al., in 2007). 
 
2.4.4 The Behaviour Rating Inventory of Executive Functions (BRIEF), see 
Appendix G. 
The BRIEF is a pen-and-paper questionnaire developed to quantify behavioural 
manifestations associated with executive functioning. It is used to assess 
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executive function behaviours in children and adolescents with an array of 
difficulties including developmental disorders and psychiatric conditions (Gioia et 
al., 2000). Mean internal consistency ratings reported for clinical populations 
using the BRIEF Parent Form range from 0.82 to 0.98. Three-week test–retest 
reliability for clinical populations on the Parent Form range from 0.72 to 0.84 
(Mahone et al., 2002). There are three versions of the BRIEF, each aimed at 
assessing a specific age range. The BRIEF–P is the preschool version for 
participants between 3 and 5 years of age, the BRIEF for age range 5-18 years, 
and the BRIEF-A which is the adult version for participants over the age of 18 
years. All three versions were used in the study, as appropriate to the age of the 
individual participant.  
 
2.4.5 The Wessex Scale, see Appendix H. 
The Wessex Scale (Kushlick et al., 1973) is used to measure adaptive 
behaviour and provides a proxy measure of degree of ID. It comprises two 
subscales including the Social and Physical Incapacity (SPI) scale and the 
Speech, Self-help and Literacy (SSL) subscale. Inter-rater reliability for the 
overall score on the SPI scale was reported at 65%, and 76% for the overall 
score on the SSL subscale (Palmer et al., 1982). 
 
 
2.5 Data Analysis 
 
2.5.1 Scoring of the instruments used 
2.5.1.1 TAND Checklist 
Individual items were scored as simple Yes/No responses. Selected 
items were grouped together to form domains and subdomains for the 
purpose of analysis along with the four external assessment tools’ total 
and subscale scores. These were a Behavioural domain (subdomains 
included ‘hyperactivity’ and ‘social communication’), a Scholastic domain, 
a Neuropsychological domain (subdomain ‘executive skills’), a Psycho-
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Table 2.1: TAND Checklist Domains of Investigation and corresponding items 
 
2.5.1.2 The SDQ 
SDQs were scored using standard scoring methods for total scores, and 
for domain scores. Impact scores were calculated using standard SDQ 
procedures by adding together the items on overall distress and social 
impairment, generating the impact score that ranges from 0-10 for the 
parent completed version. 
 
2.5.1.3 The SCQ 
In this study the SCQ was used to discriminate between individuals at risk 
of having an ASD and those who fell below the 15 point cut off. Standard 




TAND Checklist Level of 
Investigation 
TAND Checklist Items Maximum Score 
 
1. Behavioural 
   1.1. Hyperactivity 











2. Psychiatric Disorder 4a,b,c,d,e,f Yes/No 
 
2. Intellectual Yes/No Yes/No 
 
3. Academic or Scholastic 6a,b,c,d 4 
 
4. Neuropsychological 






5. Psychosocial 8a,b,c 3 
 
6. Impact Score 9 & 10 0-10 likert scale 
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2.5.1.4 The BRIEF 
Standard BRIEF scoring procedures were used for the purpose of this 
study. Parents rated their child’s behaviour on a three-point Likert scale 
(never, sometimes, and often). Eight scales were obtained (Initiate, 
Working Memory, Plan/Organize, Organization of Materials, Monitor, 
Inhibit, Shift, Emotional Control). Look-up tables across ages generated 
three main indices: a Meta-Cognition Index (MCI), Behaviour Regulation 
Index (BRI), and a Global Executive Composite (GEC). 
 
2.5.1.5 The Wessex scale 
No standardised scoring procedures for the Wessex have been published 
to date. For the purpose of this study, two researchers (the author and 
supervisor) generated consensus judgement scores of intellectual ability 
based on information provided in the Wessex questionnaire. Judgements 
were ‘normal intellectual ability’, ‘mild-moderate ID’ or ‘severe-profound’. 
Ratings were assigned blind to parental ratings and to other data. 
 
2.5.2 Statistical analysis 
Data were analyzed using SPSS Version 21. Quantitative data analysis were 
performed using non-parametric tests given the relatively small sample size. 
Item by item analysis were examined by applying the Mann-Whitney test, and 
the Chi-Square test was used for dichotomous variables. For interpretation of 
Spearman rho values generated by correlations, standard convention was used 
(see Table 2.2). Lastly, internal consistency of the TAND Checklist was 
examined by applying Cronbach’s alpha coefficient. For interpretation of 
Cronbach’s alpha values generated by correlations, see Table 2.3. 
Qualitative data were analysed using summative content analysis (Hsieh and 
Shannon, 2005), which consisted of counting and comparing keywords and 
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Table 2.2: Spearman rank-order correlation coefficient estimates for interpretation  
(Dancey and Reidy, 2004) 
 
Spearman’s rho Correlation 
0.70 and greater Very strong relationship 
0.40 to 0.69 Strong relationship 
0.30 to 0.39 Moderate relationship 
0.20 to 0.29 Weak relationship 
0.01 to 0.19 No or negligible relationship 
This descriptor applies to both positive and negative relationships 
 
Table 2.3: Cronbach’s correlation coefficient estimates for interpretation  
(Kline, 1999) 
 
Cronbach's alpha Internal consistency 
α ≥ 0.9 Excellent (High-Stakes testing) 
0.7 ≤ α < 0.9 Good (Low-Stakes testing) 
0.6 ≤ α < 0.7 Acceptable 
0.5 ≤ α < 0.6 Poor 





The study was conducted in compliance with the Declaration of Helsinki. The 
protocol was peer-reviewed in the Department of Psychiatry at the University of 
Cape Town and submitted for Ethical approval at the Faculty of Health 
Sciences, Human Research Ethics Committee (Ethics Ref 200/2013). All 
participants received information about the study, and provided written informed 
consent. No young people or individuals with intellectual disability directly 
participated in the study. All consent was therefore provided by adults. 
Participants were provided with a set amount for travel expenses (R200; ~$20), 
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Chapter 3  Results of the study 
 
3.1. Stage 1 Results – Professional and Parent expert review of the TAND 
Checklist 
 
Twenty expert feedback forms were returned by Expert Professionals. Sixty five 
percent (65% or 13/20) completed the quantitative items and 85% (17/20) 
provided both quantitative and qualitative feedback. All data were used for 
analysis. Forty two expert feedback forms were returned by expert 
parents/carers. 100% completed the quantitative items and 81% (34/42) 
completed both quantitative and qualitative questions. Results are presented 
below. 
 
3.1.1 Quantitative Feedback 
The expert feedback form asked respondents to rate five questions on a Likert 
scale from 0 to 5 with 5 as the highest score and allowed for comments on each 
question.  
 
Given the relatively small sample size, means (M), median (Mdn) and standard 
deviations (SD) are presented (see Table 3.1).  
 

















Comprehensiveness 4.62 (0.87) 5 4.60 (0.80) 5 260 0.741 
Clarity 4.31 (0.85) 4 4.48 (0.78) 5 229 0.466 
Ease of Use 4.31 (0.95) 5 4.,56 (0.79) 5 214.5 0.332 
Clinician Usage 3.77 (0.83) 4 3.43 (1.04) 3 178.5 0.232 
Subsequent Referral 4.15 (0.69) 4 4.11 (0.84) 4 236.5 0.925 
*Statistical comparison between Expert Professional and Expert Parent Scores.  
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Feedback from expert professional participants showed that the median score 
for items 1&2 were 5 out of a maximum 5 and items 3-5 were scored 4.  
Expert parents had a median score of 5 on items 1-3 relating to 
comprehensiveness, clarity and ease of use. Item 4 (‘How likely do you think 
clinicians are to use the Checklist?’) had a median score of 3. Item 5 (‘How likely 
is the Checklist to encourage clinicians to pursue further neuropsychiatric work-
up or referral to relevant specialists?’) had a median score of 4. 
 
As shown in Table 3.1, statistical comparison between expert professional and 
expert parent scores showed no significant differences.  
 
3.1.2 Qualitative Feedback  
For qualitative analysis all comments made by the expert professionals and 
expert parents (n = 51) were used. Summative analysis revealed 6 key themes, 
shown in Table 3.2. The frequency with which themes were raised by expert 
professionals or expert parents is shown in Figure 3.1.  
 
Table 3.2: Stage 1 Qualitative expert feedback about the TAND Checklist 
 
Qualitative Themes Participant Feedback 
1. Administration “I think that this checklist should be utilized by people NOT 
knowledgeable in TSC as a way of getting them to recognize that the 
Neuropsychiatric Disorders are a manifestation of the TSC“ (EX001).   
“I think it may take longer that 10 minutes if you try to describe more 
qualitative some of the “yes” responses. If it remain simple Yes-no, it 
should be fairly quick.“ (EX005) 
“I think if we could have access to it first and take it to them it would be 
more likely to be used and taken notice of.” (ATSS 001) 
2. Intellectual Ability “Definitions of degrees of intellectual disability is not given (examples 
are needed)” (EX008)  
“Hard when child is intellectually disabled, can not speak to gauge 
feedback.” (ATSS 010) 
“Difference between moderate and severe intellectual disability.” 
(ATSS 019) 
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3. Examples “Maybe include “processing speed” some patients with TSC may 
require more time to complete tasks in school or activities of daily life.” 
(EX003) 
“Not sure most people will understand “visuospatial” without further 
explanation.“ (EX004) 
“Some of the items under 5 can be difficult to understand and needs 
explanation, examples.” (TSCi002) 
4. Missing Items “Echolalia is not included but is seen frequently.“ (EX005) 
“opposition defiant disorder (ODD)” (EX010) 
“Difficulty in exploring new textures tactile.” (TSCi 008) 
5. Other Uses  “If it can be used as an educational tool as well as an evaluation and 
treatment tool.” (EX001) 
“…to guide choice of medical therapy, use of medications, or progress 
with behavioral modification therapy, it will be quite useful.” (EX005) 
 “in medical training of medical students – of TAND” (ATSS026). 
6. Driven by Parents “Again, parents need to push for follow-up! Maybe more information for 
clinicians of how to follow-up concerns – with whom.” (ATSS014) 
“As a parent you would need to insist on it often you are ’rushed 
through.’” (ATSS022) 
“Parent has to insist on this being used. Parent has to drive the care of 
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The first of the six themes identified referred to items relating to administration, 
such as where the TAND Checklist should be administered and by whom. The 
second theme that emerged centered around intellectual ability/disability (ID). 
Respondents felt it was important to establish the level of intellectual ability of a 
participant at the start of the TAND Checklist as it may influence administration 
of the remaining questions. Both Expert professionals and parents suggested 
including examples that will make it easier for parents to understand specific 
technical/medical terms such as ‘visuo-spatial skills’. There was a total of 22 
comments on missing items where parents and clinicians suggested the 
inclusion of certain items. Seven comments from the Expert professional group, 
and 2 from the parent group proposed that the TAND Checklist also be used for 
other purposes. The last theme that emerged, overwhelmingly from the parent 
group (13 comments), highlighted the need for parents to drive clinical usage of 
the TAND Checklist.  
 
Feedback from Stage 1 was used to revise the TAND Checklist (Appendix B) 
and the revised TAND Checklist was used in stage 2 of the study. 
 
3.1.3 TAND Checklist internal consistency 
3.1.3.1 Behavioural Domain 
The total number of behavioural items on the TAND Checklist (items 3a to 
3s) showed good internal consistency (α = 0.884). The hyperactivity 
subdomain items also generated a high Cronbach alpha (α = 0.751) whilst 
the social communication subdomain showed an acceptable level of internal 
consistency (α = 0.682). 
3.1.3.2 Scholastic Domain 
All four of the items in this domain showed excellent internal consistency  
(α = 0.954). 
3.1.3.3 Neuropsychological Domain 
Both the overall domain items and executive function subdomain items 
showed good internal consistency (overall α = 0.783; executive subdomain  
α = 0.792). 
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3.1.3.4 Psycho-Social Domain 
The total number of psycho-social items on the TAND Checklist (items 8a to 
8c) did not show good internal consistency (α = 0.365). 
 
 
3.2. Stage 2 Results – Face-to-face administration of the TAND Checklist 
and external validation 
 
A total of 20 parents, carers or individuals with TSC were recruited for stage 2. 
The mean age of our TSC population of 20 patients was 14.25 years (range: 3-
42 years). The gender ratio was 12:8 Male and Female. Three of the index 
cases were children with TSC of pre-school age, 4 had not received any 
schooling as they were deemed ‘ineducable’, 10 were of school-going age and 3 
were adults who had completed school.  All participants were confirmed to meet 
definite criteria for TSC (Roach et al., 1998; Krueger et al., 2013) by the primary 
clinician and the principal investigator of the study. Mutational analysis was not 
available in South Africa at the time of the study, and was therefore not included.  
 
3.2.1 Quantitative Feedback 
Table 3.3 summarises the quantitative feedback from the 20 participants. The 
median scores assigned were 5 for items 1, 2 and 5 and 4 for items 3 and 4. 
Feedback scores on items 1 and 3 ranged between 3-5, item 2 was scored 
either 4 or 5, and items 4 and 5 had a slightly broader range between 2-5. 
 
Table 3.3: Stage 2 Quantitative feedback about the TAND Checklist following face-to-face 








Item Median (n=20) Mean (SD)  
Comprehensiveness 5 4.8 (0.52) 
Clarity 5 4.95 (0.22) 
Ease of Use 4 4.45 (0.69) 
Clinical Usage 4 3.65 (0.14) 
Subsequent Referral 5 4.4 (0.88) 
	  
	   43	  
In order to determine whether live administration may have led to different 
perceptions of the TAND Checklist, results from parents in stage 2 was 
compared with parents/carers in stage 1. No statistical differences were seen 
across four of the five items between scores on Stage 2 live administration and 
Stage 1 expert parents. Interestingly item 2 (clarity) was rated as significantly 
higher in the Stage 2 live administration group (Mann-Whitney U = 249; p = 
0.003). See Table 3.4. 
 








3.2.2 Qualitative Feedback 
Nine qualitative comments were received by parents during stage 2. Given the 
live administration format in stage 2, a number of families made comments 
about the TAND Checklist during the administration. These were documented by 
the researcher as contemporaneous notes. When asked if there are any areas 
of concern about TAND not covered during its administration (TAND Checklist 
final item), participants TP001, TP013 and TP015 mentioned the family’s 
concerns regarding their child’s future. TP003 raised concerns about social 
issues. Comments regarding missing items included “listening skills and 
emotional: cries a lot” (TP007) and “toilet training at school and fine motor 
control” (TP011).  Participant TP009 recommended including items relating to 
family dynamics “relationship within marriage and with siblings”. TP002 wanted 
to know more about TSC, “Where does TSC come from?” and participant TP015 
asked about “the genetics of TSC and the impact of biological manifestations”.  
 
 
Item Expert Parent Stage 
1 and Parent Stage 2 
Mann-Whitney U 
Expert Parent Stage 
1 and Parent Stage 2 
P-value  
Comprehensiveness 364 0.259 
Clarity 249 0.003* 
Ease of Use 341.5 0.362 
Clinical Usage 311.5 0.482 
Subsequent Referral 292.5 0.162 
	  
	   44	  
3.2.3 Correlation between TAND Checklist domains and External Assessment 
Tools 
The TAND Checklist consists of a number of domains and subdomains as 
outlined in Table 3.5.  
 





External validation therefore aimed to compare domains and subdomains with 
relevant well-validated external tools. Results are outlined for the Behavioural 
domain (in relation to the SDQ and SCQ), the Intellectual ability domain (in 
relation to the Wessex), the Neuropsychological domain (in relation to the 
BRIEF), the Scholastic domain (in relation to the Wessex), the Psycho-Social 
domain (in relation to the SDQ) and finally, the overall Impact score (in relation 
to clinician impact rating and impact scores on the SDQ). 
 
Results are shown in Figures 3.2-3.7 and Tables 3.6 and 3.7 
 
3.2.3.1 Behavioural Domain 
Figure 3.2 shows the correlation between the total number of behavioural 
items endorsed on the TAND Checklist (items 3a to 3s) and the total 
difficulties score on the Strength and Difficulties Questionnaire (SDQ). 
Results show a strong positive correlation (Rho = 0.81; p < 0.001).  
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Figure 3.2: TAND Total Behaviour Score and SDQ Total Difficulties Score 
 
3.2.3.1.1 Hyperactivity behaviours 
In order to examine hyperactivity-related behaviours, the 
TAND Checklist hyperactivity subdomain items (items 3n – 
3q) were plotted against the hyperactivity/inattention domain 
items of the SDQ (Fig. 3.3). Results showed a strong 
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3.2.3.1.2 Social-Communication behaviours 
Figure 3.4 shows the correlation between the TAND 
Checklist social communication subdomain items (items 3h 
– 3m) and the total scores on the Social Communication 
Questionnaire (SCQ). Results show a strong linear 
correlation between the TAND Checklist and the SCQ  
(Rho = 0.70; p = 0.002). The SDQ pro-social domain is a 
measure of positive or pro-social behaviours, predicted to 
correlate inversely with social-communication difficulties. 
Results confirmed a strong negative correlation  
(Rho = -0.65; p = 0.002) between the pro-social domain of 





Figure 3.4: TAND Social Communication Score and SCQ Total Score 
 
3.2.3.2 Intellectual Ability Domain 
In item 5, parents were asked about intellectual disability in their 
child/family member. Parental judgement of the presence/absence of ID 
was compared to researcher judgement based on the Wessex 
questionnaire scores. Cross-tabulation of findings are shown in Table 3.6 
The two-by-two contingency table showed a significant association 
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Table 3.6: Cross-tabulation of relationship between parental intellectual ability concern and 




3.2.3.3 Neuropsychological Domain 
Figure 3.5 shows the neuropsychological domain score (items 7a – 7f) 
plotted against the Global Executive (GEC) Score of the BRIEF. Results 
show a strong positive correlation between the two measures  
(Rho = 0.79; p < 0.001). The BRIEF behaviour rating index (BRI) score 
correlated strongly with the neuropsychological domain score of the 
TAND Checklist (Rho = 0.74; p = 0.001). The BRIEF metacognition index 
(MI) score correlated moderately with the TAND neuropsychological 
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3.2.3.3.1 Executive Functioning 
Given the fact that the TAND Checklist Neuropsychological 
domain included a number of executive skills (specifically 
measured in the BRIEF), it was important to examine 
executive skills specifically. The correlation between the 
TAND Checklist executive skills subdomain items (items 7b 
– 7e) and the BRIEF GEC score showed a strong 
correlation (Rho = 0.79; p < 0.001). Similarly when 
correlating the BRIEF BRI score with the TAND Checklist 
executive skills subdomain, there was a strong correlation 
(Rho = 0.75; p = 0.001) (see Fig. 3.6). The BRIEF MI score 
also correlated (Rho = 0.65; p = 0.006) and showed a 
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Figure 3.6: TAND Executive Function Score and BRIEF Behaviour Rating Index 
 
 
3.2.3.4 Scholastic Domain 
No external tools that specifically evaluated scholastic/academic skills 
were included in this study. However, we predicted that individuals with a 
lower Wessex score, suggesting intellectual disability, would have higher 
rates of scholastic difficulties reported in their TAND Checklists. Eighty 
percent (16/20) of participants were of school-going age or above and 
could be examined for scholastic difficulties. The TAND Checklist 
identified 7 individuals with scholastic difficulties of whom 6 were found to 
have ID as per Wessex judgement score.  
 
3.2.3.5 Psycho-Social Domain 
Individuals with psycho-social difficulties have an increased likelihood of 
behavioural challenges, including emotional and peer difficulties. We 
were therefore interested in the correlation between the TAND psycho-
social domain and performance on the SDQ. Findings indicated moderate 
positive correlations between the TAND psycho-social scores and SDQ 
total difficulties (Rho = 0.593; p = 0.006) and between the TAND psycho-
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Interestingly TAND psycho-social scores did not correlate with SDQ peer 
problems (Rho = 0.221; p = 0.350).   
 
3.2.3.6 Impact Scores 
The Strengths and Difficulties Questionnaire contains a section that 
generates an impact score. In order to determine the association between 
the SDQ impact score and the TAND Checklist impact scores (TAND 
Checklist items 9 and 10) correlation analysis was applied to the SDQ 
impact score and the impact score assigned by the parent (item 9) and 
clinical researcher (item 10). See Figs. 3.7 and 3.8. A moderate 
correlation was found when comparing the SDQ impact score with that 
assigned by parents (Rho = 0.561; p = 0.010).  There was however a very 
strong correlation (Rho = 0.796; p < 0.001) between SDQ impact score 




Figure 3.7 Stage 2: Correlation between impact score assigned by parent and 
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Figure 3.8 Stage 2: Correlation between impact score assigned by clinician and 
impact score generated from SDQ. 
 
 
When looking at impact scores assigned by parents and the researcher 
respectively, 2 parents under-rated the impact, 9 agreed with the researcher’s 
judgement and a further 9 parents assigned over-rated scores. 
 
 
3.3. Stage 3 Results – Demographic profile of study participants 
Demographic characteristics of the study participants are summarised in  
Table 3.7.  
 
The aim in Stage 3 of this pilot study was to obtain a general sense of the study 
participants, to show how similar or different our participants were from the 
general population. In comparison with the general population, the Western 
Cape province of South Africa is not representative of national statistics in 
relation to employment, income and formal housing. For this reason we did not 
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Table 3.7: Demographic information of the families who participated in Stage 2 live 
administration of the TAND Checklist (n=20) 
 
 
*Parental Education: Grade numbers indicate highest level of primary education (up to grade 7) or secondary 
education (grade 8-12); ‘Certificate’ indicates a Grade 10-11 equivalent; ‘degree’ indicates Tertiary education 
 
 
According to Statistics South Africa (2013), the general population is estimated 
at 52,982 million, roughly 6 million (11%) of whom live in the Western Cape. 
More than 1.3 million South Africans lived in informal dwellings in 2012 of which 
135 000 (~10%) reside in the Western Cape. Nineteen of the twenty 
participating families were from urban areas around Cape Town, and only one 
family was from a rural community/informal settlement. In South Africa, ‘rural 
living conditions’ would include living on farmlands or in townships around major 
cities, most of which are not situated in the Western Cape.  
With regard to family income, Figure 3.9 shows the monthly income of families.  













TP001 Male 12 Urban 5-10k Grd 12 none Special Ed 
TP002 Male 13 Rural <3k Grd 11 none None 
TP003 Female 3 Urban <3k Grd 10 not yet None 
TP004 Male 15 Urban <3k Grd 7 9 Special Ed 
TP005 Female 3 Urban <3k Grd 10 none None 
TP006 Female 27 Urban <3k Grd 10 adult Special Ed 
TP007 Female 5 Urban <3k Grd 11 none Special Ed 
TP008 Male 10 Urban <3k Grd 10 4 Mainstream 
TP009 Male 13 Urban 5-10k Grd 11 5 Special Ed 
TP010 Male 16 Urban <3k Grd 7 10 Private 
TP011 Male 6 Urban <3k Grd 12 1 Mainstream 
TP012 Male 9 Urban 10-15k Grd 12 2 Mainstream 
TP013 Female 19 Urban <3k Certificate none None 
TP014 Male 13 Urban 15-20k Grd 12 7 Special Ed 
TP015 Female 5 Urban 20k + Degree R Private 
TP016 Female 19 Urban 5-10k Certificate none Special Ed 
TP017 Male 36 Urban 20k+ Degree Adult Mainstream 
TP018 Male 8 Urban 20k+ Degree 2 Special Ed 
TP019 Male 42 Urban 20k+ Degree Adult Mainstream 
TP020 Female 11 Urban 20k+ Degree 5 Mainstream 
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statistical release, Monthly earnings of South Africans 2010, by Statistics South 
Africa in November 2010 the median monthly earnings were R2,800 (~$280). 
Whilst earnings in the Western Cape were R2,700 (~$270) per month, it is 
important to note that its poorest 5% had the highest earnings amongst the 
poorest paid in all of the 9 provinces in South Africa. In our cohort, 50% of 
participating families earned less than R3,000 per month (~US$300), 15% 
earned between R5,000 and R10,000 per month (~$500-$1,000), 5% between 
R10,000 and R15,000, a further 5% between R15,000 and R20,000 and the 
remaining 25% earned more than R20,000 per month (~US$2,000).  
In terms of level of education, the National Senior Certification (NSC), also 
referred to as ‘matric’, is the equivalent of Grade 12 education.  The 2011 NSC 
examination results showed that 70.2% of full-time school candidates passed 
this examination whilst 82.9% of candidates in the Western Cape passed 
(Department of Basic Education, 2011). Interestingly, the 25% of families in our 
study who had showed monthly earnings exceeding R20 000 attained degree 
level education, whilst the remaining 75% ranged from Grade 7 (end of primary 




      
Figure 3.9: Combined Monthly Family Income 
Combined	  Monthly	  Family	  Income	  
<	  R3000	  (<$300)	  
R5000	  -­‐	  R10	  000	  ($500-­‐
$1000)	  
R10	  000	  -­‐	  R15	  000	  ($1000-­‐
$1500)	  
R15	  000	  -­‐	  R20	  000	  ($1500-­‐
$2000)	  
>	  R20	  000	  (>$2000)	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Participants reported that 12 (60%) of the TSC patients had a history of 
epilepsy, 4 (20%) had received a diagnosis of intellectual disability, 3 (15%) had 
a diagnosis of ADHD, and 1 (5%) patient had received a diagnosis of a mood 
disorder. None of the participants in the study had received a diagnosis of an 
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Chapter 4  Discussion 
 
 
The purpose of the study was to perform a pilot validation of the TAND Checklist 
in order to create an acceptable TAND Checklist for larger-scale clinical use and 
research exploration. The pilot study focused on face and content validity, in 
order to establish whether the TAND Checklist was perceived to be 
comprehensive, clear, easy to use, applicable in real life settings and to 
determine whether it is likely to lead to further neuropsychiatric evaluation. In 
addition, the pilot examined external validation by comparing TAND Checklist 
scores to performance on a battery of widely-used and validated rating scales. 
Qualitative and quantitative data were used to refine the TAND Checklist. 
 
 
4.1. Feedback on the TAND Checklist 
 
The first aim of this study was to gather feedback to guide the refinement of the 
first version of the TAND Checklist. Results from the expert feedback form as 
completed by expert professionals, expert parents and parents in face-to-face 
administration showed high scores across the main areas of face and content 
validity. Taken together, results suggested that the TAND Checklist was 
regarded to be comprehensive, clear, easy to use, applicable and that it may 
lead to increased next-step assessments or treatments. Feedback was 
deliberately sought from numerous countries (28) with the aim of collecting 
global opinions and feedback. The hope is therefore that the tool would have a 
global utility. Feedback from participants was consistent suggesting that the 
TAND Checklist is generalisable/transferable and useful to clinicians and 
families. 
 
One item showed a lower median score among expert professionals and expert 
parents. Results from item 4 (clinical usage) indicated hesitation as to whether 
clinical teams would use the TAND Checklist in practice. It is possible that there 
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may have been concern regarding the time requirements to complete the tool in 
the context of a busy clinic schedule, or that experts did not feel that they would 
have the necessary competence to complete the TAND Checklist with families. 
It was therefore interesting to note a strong theme from expert parents about the 
need for parents/families to take ownership and drive usage of the TAND 
Checklist. 
 
No statistical differences were noted between responses of expert professionals 
and expert parents in stage 1. It was therefore interesting to observe a 
statistically significant difference between the Expert parents in Stage 1 and 
Stage 2 live administration participants with regards to item 2 addressing clarity. 
We interpret this to suggest that face-to-face administration of the TAND 
Checklist lead to increased clarity, providing good support for the face-to-face 




4.2 Internal consistency 
 
Examination of internal consistency suggested that the TAND Checklist has 
acceptable to excellent internal consistency within the domains and subdomains 
measured. However, the items from the Psycho-Social domain did not appear to 
have good internal consistency. These items do not refer to specific behaviours 
or outcomes, but rather to the subjective interpretation of the respondent. 
Furthermore, these 3 items refer to 2 separate constructs i.e TSC individual’s 
self esteem; and parental and family stress. Thus, we did not anticipate them to 
render high internal consistency.  
 
4.3 External validation 
One of the main objectives of the study was to investigate external validity of the 
TAND Checklist, specifically concurrent validity, within particular domains and 
subdomains of the TAND Checklist.  
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4.3.1 Behavioural Domain 
The behavioural domain items of the TAND Checklist correlated very strongly 
with the total difficulties score of the Strengths and Difficulties Questionnaire 
(SDQ). This indicated good convergent validity, that is, correspondence between 
the behavioural items in the TAND Checklist and similar behavioural constructs 
identified in the SDQ. Results showed that the behavioural domain of the TAND 
Checklist can be used as an effective indicator of behavioural difficulties 
associated with TSC. Results within the subdomain of hyperactivity also showed 
strong correlation between items associated with hyperactivity in the TAND 
Checklist and the total hyperactivity/inattention score produced by the SDQ 
assessment tool. The TAND Checklist social communication subdomain 
constructs correlated strongly with items from the Social Communication 
Questionnaire (SCQ), highlighting behaviours associated with autism spectrum 
disorders. Findings suggested that these items may be very useful markers of 
risk for ASD which is known to have a very high prevalence in TSC. The 
negative correlation seen between the SDQ Pro-social scale and the TAND 
social-communication items further strengthen the external validity of the items 
included in the TAND Checklist. Overall, results from the behavioural domain 
suggested that ADHD-related and ASD-related behaviours, two key 
developmental challenges in TSC, may usefully be identified through the TAND 
Checklist. 
 
4.3.2. Intellectual Ability Domain 
There was a moderate correlation between the level of intellectual ability as 
perceived by parents and researcher judgement based on the Wessex scale. 
Results suggest that parental perception of intellectual development is generally 
reasonably accurate. The TAND Checklist may be particularly helpful to identify 
individuals where there is a particular discrepancy between parental perception 
and clinical judgement. Given the multi-componential nature of intelligence, this 
might be a particular group of individuals who would benefit from formal 
assessment of their intellectual strengths and weaknesses.  
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It is important to emphasise that the TAND Checklist is not proposed to be a 
valid or reliable tool to measure or identify intellectual disability. However, it is 
known that about 50% of individuals with TSC may have intellectual disability, 
and that in turn shows very strong correlations with many neuropsychiatric and 
physical challenges. For these reasons, it may be very helpful to use the TAND 
Checklist to have a positive conversation with families about intellectual 
development and ability.  
 
4.3.3   Neuropsychological Domain 
The majority of individuals with TSC will have some neuropsychological deficits, 
even if they have normal intellectual ability (Harrison et al., 1999; Ridler et al., 
2007; de Vries et al., 2008; de Vries, 2010b; Tierney et al., 2011). Many of the 
behavioural screening tools for neuropsychological deficits are complicated to 
administer and score, and are expensive. It was therefore important to 
determine whether the neuropsychological questions in the TAND Checklist 
might provide a useful index of potential neuropsychological, and in particular 
executive, deficits. The TAND Checklist showed very strong correlation with the 
Behaviour Rating Inventory of Executive Functions (BRIEF), a widely-used and 
highly regarded rating scale. There were strong correlations when comparing 
the total TAND neuropsychological score with the global executive score (GEC) 
and behaviour rating index (BRI) of the BRIEF, suggesting that the TAND 
Checklist may be useful to highlight broad overall neuropsychological concerns 
and behaviour related difficulties such as inhibition, shifting between tasks or 
emotional control. The moderate correlation observed between the TAND total 
score and the metacognition index (MI) of the BRIEF suggested that the TAND 
Checklist did not fully capture the finer constructs identified by the MI including 
initiation, working memory, planning or organising and monitoring skills. It was 
very encouraging that the TAND Checklist executive function (EF) subdomain 
correlated strongly with all three subscales of the BRIEF. Taken together, results 
suggested that the TAND Checklist may be very helpful in identifying potential 
neuropsychological and in particular executive difficulties that would benefit from 
further evaluation and intervention.  
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4.2.3 Scholastic Domain 
This pilot did not include any external validation instruments in the scholastic 
domain that could have examined the TAND Checklist items in a robust way, 
and this domain in particular would benefit from evaluation in future studies. It 
was however encouraging that, as predicted, there was a good correlation 
between those identified as having intellectual disability on the Wessex and the 
presence of scholastic problems in reading, writing, spelling and/or 
mathematics. 
 
4.2.4 Psycho-Social Domain 
Correlations indicated that the TAND Checklist was able to identify psycho-
social difficulties in TSC, but only moderately when compared to the Strengths 
and Difficulties Questionnaire (SDQ) total score and sub-scale of emotional 
symptoms. No correlation was observed between the TAND Checklist psycho-
social domain and the SDQ sub-scale for peer relationships. Results suggested 
that the TAND Checklist might be able to identify behavioural difficulties 
associated with emotional concerns, but not sufficiently regarding peer 
relationships. Taken together, findings suggest that the psycho-social items in 
the TAND Checklist could best be viewed as a starting place for conversations 
around self-esteem, family relationships and peer interactions, and that further 
exploration should take place in order to identify relevant clinical needs.  
 
4.2.5 Impact Scores 
The impact rating assigned by parents correlated very strongly with that 
assigned by the researcher indicating that the TAND Checklist was able to 
quantify the degree and impact of neuropsychiatric problems experienced by 
families and individuals living with TSC. The researcher impact scores 
correlated better with the Strengths and Difficulties Questionnaire (SDQ) impact 
score than the parent-rated impact score. These results support two potentially 
valuable contributions of the TAND Checklist. Firstly, it indicated that a clinician 
can generate a reasonably good sense of the impact of the neuropsychiatric 
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challenges of an individual with TSC after this short interview. Secondly, it 
supports the value of an external perspective of ‘impact’. Where a family under-
rated the impact (2 families), this could lead to a very helpful conversation 
regarding ways to find support; where a family over-reported impact (9 families), 
this may lead to a conversation around family stress, support systems and how 
to manage challenges. 
 
 
4.4 Demographic Data 
 
The final aim of the study was to gather demographic data of the families and 
individuals with TSC who participated in the study to show how similar or 
different our participants were from the general population. We did not anticipate 
our cohort to be fully representative of the general population as our sample was 
recruited from the Western Cape Province where unemployment rates are 
lower, access to amenities more readily available, and where level of education 
is highest (Stats SA, 2010; Department of Basic Education, 2011; Stats SA, 
2013). Only a single family reported living in a rural setting, in keeping with the 
Western Cape’s lower than national informal settlement rates. An interesting 
finding was that the quarter of families with monthly earnings exceeding 
R20,000 (~$2,000) also attained degree level education - an indication of the 
relationship between income and level of education.  
 
The prevalence of epilepsy, intellectual disability and symptoms of mood 
disorders in this cohort (60%; 20%; 5%) were consistent with previous studies. 
With regards to autism spectrum disorders and attention deficit hyperactivity 
prevalence rates (0%; 15%) clinical diagnosis in this population was not in 
keeping with the literature (Smalley et al., 1994; Gillbert et al., 1994; Thiele, 
2004; Prather and de Vries, 2004; de Vries, 2007; de Vries, 2010b).  We predict 
that this is most likely due to under-diagnosis given that the four external 
assessment tools used, as well as the TAND Checklist, identified a substantial 
number of participants at high risk for ASD or ADHD. It would be an important 
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next step in future studies to examine whether high scores on the TAND 
Checklist a) lead to further evaluations and b) correlate with clinical diagnoses 
of, for instance, autism spectrum disorder or ADHD. 
 
 
4.5 Limitations of the study 
 
In spite of the positive initial findings of this pilot study, there are several 
limitations that should be acknowledged.  
 
1. Concern regarding age ranges of the rating scales selected for concurrent 
validation of the TAND Checklist. The Strengths and Difficulties Questionnaire 
(SDQ) used in this study was aimed at individuals between the ages of 4 and 10 
years and 11 – 17 years. This study had 2 participants below the age of 4 (both 
were 3.5 years of age) and a further 5 participants who were over the age of 17. 
The items and subscale may still be appropriate, however, there has been no 
validation studies to our knowledge on very young children or in the adult 
population. In contrast, three versions of the BRIEF were available and used in 
the study. 
 
2.1 Selection of respondents required to complete the questionnaire. The tool 
used to establish concurrent validity with social communication problems on the 
TAND Checklist was the Social Communication Questionnaire (SCQ). The 
questionnaire was designed to be completed by the parent of an individual with 
possible ASD. However, during stage 2 live administration, the 5 adult 
participants did not have a parent/carer who could complete the SCQ about 
them. In these instances, participants completed the SCQ about themselves. 
These adults were unable to answer the questions that referred to behaviours 
before the age of 5 years of age. However, it is important to note that none of 
these 5 adult participants showed any signs of autistic-like behaviour on the 1st 
half of the questionnaire or in the social communication items of the TAND 
Checklist.  
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2.2 Assessment tools used. Albeit a reliable tool, the Wessex scale does not 
render an overall score or cut off point and the researcher needed to assign a 
judgement score to enable analysis. To mitigate this aspect of the tool, 
judgement scores were assigned by a pair of researchers with consensus.  
 
These limitations with regards to the external assessment tools used also 
support the development of the TAND Checklist which has one single version for 
all ages, abilities and can be completed with a parent, carer or individual with 
TSC. 
 
3. Aspects of reliability. It is important to acknowledge that this study did not 
examine certain aspects of reliability such as inter-rater or test-retest reliability. It 
might be very helpful to examine inter-rater reliability, in particular to see if 
relatively non-expert clinicians will get similar scores to very experienced TSC 
clinicians. Interestingly, in this study, the face-to-face administration was done 
by a non-clinician with relatively little experience in TSC. The reatively positive 
results on external validation suggest that a high level of clinical and TSC 
expertise may not be required. Whilst test-retest reliability is often examined for 
questionnaires, it is not clear how useful this would be for a TAND Checklist, 
given that new neuropsychiatric manifestations may present over the course of a 
few weeks, thus reducing the likelihood of high stability of measurement.  
 
4. Subsequent validity. One of the aims of the TAND Checklist is to address the 
vast gap between need and actual assessment and treatment of 
neuropsychiatric disorders in TSC by acting as an aide-mémoire to clinicians. In 
order to establish subsequent validity, one would have to look at clinical usage 
of the TAND Checklist in practice and it is suggested that future research 
include this aspect of validity. It was however encouraging that qualitative data 
from parent and professional experts suggested a good likelihood of ‘next steps’ 
subsequent to administration of the TAND Checklist. 
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5. Sensitivity and specificity. It was outside the scope of this study to examine 
sensitivity and specificity of the tool. These measures of performance would be 
a natural next step in terms of validating the TAND Checklist as both a reliable 
and valid tool in identifying neuropsychiatric difficulties in TSC. 
 
6. Language constraints. The stage 2 live administration participants were all 
from the Western Cape in South Africa and were required to understand 
English. South Africa has 11 official languages and it is therefore possible that 
the requirement for English may have introduced some bias in ascertainment. 
English is however generally understood across the country, being the language 
of business, politics and media (statistics south Africa, 2012), and the research 
team encouraged participation across all language groups by ensuring that there 
was access to English, Afrikaans and isiXhosa speaking staff for families and 
participants. In spite of these potential language challenges, results were 
extremely encouraging and suggested that the TAND Checklist may still be 
helpful and a valid tool across the vast majority of neuropsychiatric domains, 




4.6 Future Directions 
 
The next step involves the translation of the TAND Checklist into a range of 
international languages including Spanish, Portugese, Chinese, Flemish, French 
and German. In addition, South African translations will be made into the high-
frequency languages (Afrikaans, isiXhosa and isiZulu). A standard procedure for 
translation and back-translation will be used, and all translated versions will be 
authorised by the primary authors of the tool to ensure accurate and consistent 
translations of the TAND Checklist. TAND Checklists will be made available via 
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This was the first study to focus on refining the TAND Checklist and to 
investigate aspects of its validity. Further larger scale research is required to 
investigate other features of the TAND Checklist’s validity and reliability not 
examined in the pilot validation. Clinicians and researchers may benefit from 
training on usage of the TAND Checklist, both in a clinical and research settings. 
Once the TAND Checklist is in clinical use (2014), it is imperative that follow-up 
research focuses on potential ‘next steps’ where neuropsychiatric concerns are 
identified, ultimately addressing the vast gap between need and treatment. 
Families and clinicians may also benefit from a toolkit containing ‘next steps’, 
‘self-help’ information and access to resources, especially in countries and areas 
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Chapter 5  Conclusion  
 
 
As outlined in Chapter 1, TSC is a genetic condition with an immense range of 
physical manifestations that can be very challenging to manage. Good progress 
has been made in recent decades to improve earlier diagnosis and early 
treatment (particularly of seizures). Molecularly targeted treatments have 
brought new medical treatments for some of the key physical features of TSC 
(de Vries, 2010a; Manning, 2010; Krueger et al., 2013). 
 
TSC is also associated with a significant range of neuropsychiatric disorders and 
these have an enormous impact on the quality of life for individuals with TSC 
and their families. In contrast to the improved detection and treatment of 
physical manifestations of TSC, there is still a significant ‘assessment and 
treatment gap’ of neuropsychiatric difficulties in TSC (de Vries, 2013). The 
needs of an individual may change over time as some developmental difficulties 
improve or become more pronounced, or as new mental health, school or family 
difficulties emerge. Given the range of manifestations, the age and 
developmental variability, there have been to date no simple or single screening 
tool to help clinicians and families evaluate an individual with TSC for possible 
neuropsychiatric features. The coining of the term TAND (TSC-Associated 
Neuropsychiatric Disorders), the 2012 Neuropsychiatry Panel recommendation 
to perform annual screening for TAND, and the TAND Checklist were all initiated 
with the aim of improving awareness of TAND, and to encourage a systematic 
approach to TAND. 
 
In this research project, we performed the first evaluation of the TAND Checklist 
as outlined in Chapter 2. Given the interest in the TSC community in getting 
access to the TAND Checklist, it was important to do a first-step evaluation to 
ensure that the TAND Checklist was appropriately comprehensive, clear and 
usable to clinicians and families. In addition, we were interested to determine 
whether clinicians and families felt that the TAND Checklist would be useful and 
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would encourage further assessment or treatment (so-called subsequent 
validity). The results of expert feedback forms and of parental feedback (Chapter 
3) suggested that overall the TAND Checklist was deemed to be a good tool in 
identifying possible neuropsychiatric difficulties. Qualitative feedback provided 
information for minor improvements to the TAND Checklist (including an 
additional section on developmental history, examples provided for terms such 
as ‘visuo-spatial skills’ and ‘executive functions’, and the reduction/collapse of 
intellectual ability/disability categories to eliminate confusion and 
misinterpretation), and raised the importance of families leading the use of the 
TAND Checklist in partnership with their clinical teams.  
 
Given that the TAND Checklist items had not been validated in any other setting, 
it was also important to check external validity by comparing the domains on the 
TAND Checklist with external tools that had already been validated and/or used 
widely (Chapter 2). We deliberately chose to perform pilot validation in South 
Africa where we expected baseline knowledge not to be very high, where levels 
of academic and socio-economic status, and competence in English would be 
quite variable. We argued that the tool needed to be such that it would be easily 
accessible to individuals from low/middle income countries. In addition, we also 
piloted the TAND Checklist with a researcher (the author) who does not have a 
clinical qualification or extensive expertise in TSC, to determine whether relative 
non-expert administrators could still collect meaningful and relevant 
neuropsychiatric information. Results of the concurrent/external validation were, 
on the whole, very encouraging (Chapter 3). The majority of domain and 
subdomain scores correlated strongly to very strongly with the external rating 
scales used in the study. Modest correlations were seen in the psycho-social 
domain, and we did not use any external validation tools for the scholastic or 
psychiatric levels, where actual clinical evaluation would have been required. 
 
We acknowledged the range of limitations of the study (Chapter 4). However, it 
was very encouraging to observe that one simple tool that takes approximately 
10 minutes to complete captured information relevant to TSC in a way that 
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correlated very well with 4 external tools (which took on average an hour to 
complete) and which would cost ~R2,500 (~$250) if used commercially. The 
TAND Checklist will be freely available to clinicians and researchers globally. 
 
The third and final version is currently in the process of being translated into 
other languages for clinical use and will be made available in early 2014. Further 
subsequent validity research studies will need to be performed to ascertain 
whether annual screening of TAND will address the ‘need and 
assessment/treatment gap’ of neuropsychiatric disorders. The TAND Checklist 
will play a critical role in achieving this goal set out by the Neuropsychiatric 
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Appendix A: TAND Checklist v.1 
 
The	  TAND	  Research	  Checklist	  (2012)	  
Lifetime	  version	  (TAND-­‐CL)	  
	  
Tuberous	  Sclerosis	  Complex	  (TSC)	  is	  associated	  with	  a	  range	  of	  neuropsychiatric	  
disorders	  which	  we	  refer	  to	  as	  TAND	  (TSC-­‐Associated	  Neuropsychiatric	  Disorders).	  	  
	  
	  
All	  people	  with	  TSC	  are	  at	  risk	  to	  have	  some	  of	  these	  difficulties.	  Some	  people	  with	  
TSC	  have	  very	  few	  of	  these	  issues,	  while	  others	  will	  have	  many	  of	  these	  difficulties.	  
Each	  person	  with	  TSC	  will	  therefore	  have	  their	  own	  TAND	  profile,	  and	  this	  profile	  
may	  change	  over	  time.	  This	  checklist	  was	  developed	  to	  help	  clinical	  teams	  and	  
families	  a)	  screen	  for	  TAND	  at	  every	  clinic	  visit	  and	  b)	  prioritize	  with	  families	  what	  
to	  do	  next.	  
	  
Instructions	  to	  use	  the	  checklist.	  
The	  TAND	  checklist	  was	  designed	  to	  be	  completed	  by	  a	  clinician	  with	  relevant	  
knowledge	  and	  experience	  in	  TSC	  in	  partnership	  with	  an	  individual	  with	  TSC,	  their	  
parents	  or	  carers.	  The	  checklist	  should	  take	  about	  10	  minutes	  to	  complete.	  Where	  
individuals	  answer	  YES	  to	  an	  item,	  the	  clinician	  should	  explore	  the	  difficulty	  in	  
sufficient	  detail	  to	  help	  guide	  decisions	  about	  further	  evaluation	  or	  treatment.	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All	  items	  should	  be	  completed.	  
	  
________________________________________________________________________________________________	  
As	  you	  will	  know,	  the	  majority	  of	  people	  with	  TSC	  have	  some	  difficulty	  in	  
learning,	  behaviour,	  mental	  health,	  specific	  aspects	  of	  their	  development	  and	  
so	  on.	  We	  are	  going	  to	  use	  this	  checklist	  to	  help	  us	  check	  for	  these	  kinds	  of	  
difficulties.	  I	  am	  going	  to	  ask	  a	  number	  of	  questions.	  Some	  may	  be	  directly	  
relevant	  to	  you;	  some	  might	  not	  be	  at	  all.	  Just	  answer	  as	  best	  as	  you	  can.	  At	  




1.	  Firstly	  we	  will	  talk	  about	  behaviours	  causing	  concern	  to	  you	  or	  to	  other	  
people.	  
Have	  you/your	  child/your	  family	  member	  ever	  had	  difficulties	  with	  any	  of	  
the	  following?:	  
 
a.	  Anxiety	   NO	   YES	  
b.	  Depressed	  mood	   NO	   YES	  
c.	  Extreme	  shyness	   NO	   YES	  
d.	  Mood	  swings	   NO	   YES	  
e.	  Aggressive	  outbursts	   NO	   YES	  
f.	  Temper	  Tantrums	   NO	   YES	  
g.	  Self-­‐injury	  such	  as	  hitting,	  biting,	  scratching	  self	   NO	   YES	  
h.	  Absent	  or	  delayed	  onset	  of	  language	  to	  communicate	   NO	   YES	  
i.	  Unusual	  use	  of	  language,	  such	  as	  strange	  words	  or	  
sentences	  
NO	   YES	  
i.	  Poor	  eye	  contact	   NO	   YES	  
j.	  Difficulties	  getting	  on	  with	  other	  people	  of	  similar	  age	   NO	   YES	  
k.	  Repetitive	  behaviours	  such	  as	  doing	  the	  same	  thing	  over	  
and	  over	  again	  
NO	   YES	  
l.	  Very	  rigid	  or	  inflexible	  about	  how	  to	  do	  things	  and	  not	  
liking	  change	  in	  routines	  
NO	   YES	  
m.	  Overactivity/hyperactivity	   NO	   YES	  
n.	  Difficulty	  paying	  attention	  or	  concentrating	   NO	   YES	  
o.	  Restlessness,	  fidgetiness	   NO	   YES	  
p.	  Impulsivity	  such	  as	  butting	  in,	  not	  waiting	  turn	   NO	   YES	  
q.	  Difficulties	  with	  eating	  (too	  much,	  too	  little,	  unusual	  
things)	  
NO	   YES	  
r.	  Sleep	  difficulties	  such	  as	  with	  falling	  asleep	  or	  waking	  in	  
the	  night	  
NO	   YES	  
If	  you	  answered	  YES	  to	  any	  of	  the	  above:	  
	  
Have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	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2.	  Problem	  behaviours	  may	  add	  up	  to	  meet	  criteria	  for	  specific	  psychiatric	  
disorders.	  Have	  you/your	  child/family	  member	  received	  a	  diagnosis	  of:	  
	  
a.	  Autism	  Spectrum	  Disorder	  (ASD),	  including	  autism,	  
asperger’s	  etc.	  
NO	   YES	  
b.	  Attention	  Deficit	  Hyperactivity	  Disorder	  (ADHD)	   NO	   YES	  
c.	  Anxiety	  Disorder	   NO	   YES	  
d.	  Depressive	  Disorder	   NO	   YES	  
e.	  Obsessive	  Compulsive	  Disorder	  (OCD)	   NO	   YES	  
f.	  Psychotic	  Disorder	  	   NO	   YES	  
If	  you	  answered	  YES	  to	  any	  of	  the	  above,	  have	  you	  had	  
further	  evaluation	  or	  support	  for	  it?	  
	  











3.	  About	  half	  of	  people	  with	  TSC	  will	  have	  significant	  
difficulties	  in	  their	  overall	  intellectual	  development	  and	  
may	  have	  ‘intellectual	  disability’.	  Have	  you	  ever	  been	  











If	  YES,	  have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
	  








What	  is	  your	  view	  of	  your	  own/your	  child’s/your	  family	  member’s	  
intellectual	  ability?	  (circle)	  
	  
Normal	  Intellectual	  Ability	  
Mild	  or	  Moderate	  Intellectual	  Disability	  
Severe	  Intellectual	  Disability	  
Profound	  Intellectual	  Disability	  
	  
	  
4.	  Many	  people	  with	  TSC	  who	  are	  of	  school	  age	  will	  have	  difficulties	  in	  school.	  
Do	  you/your	  child/family	  member	  have	  any	  difficulty	  with	  one	  of	  the	  
following:	  
	  
a.	  Difficulties	  with	  reading	   NO	   YES	  
b.	  Difficulties	  with	  writing	   NO	   YES	  
c.	  Difficulties	  with	  spelling	   NO	   YES	  
d.	  Difficulties	  with	  mathematics	   NO	   YES	  
If	  YES,	  have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	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an	  Individual	  Educational	  Plan	  (IEP)	  or	  any	  additional	  
support	  in	  school?	  
	  











5.	  The	  majority	  of	  people	  with	  TSC	  will	  have	  some	  difficulties	  in	  some	  specific	  
brain	  skills.	  Do	  you/your	  child/family	  member	  have	  any	  difficulties	  with	  any	  
of	  the	  following	  brain	  skills:	  
	  
a.	  Memory,	  such	  as	  remembering	  things	  that	  have	  happened	   NO	   YES	  
b.	  Attention,	  such	  as	  concentrating	  well,	  not	  getting	  
distracted	  
NO	   YES	  
c.	  Dual-­‐tasking/	  Multi-­‐tasking	   NO	   YES	  
c.	  Visuospatial	  tasks,	  such	  as	  spatial	  navigation	   NO	   YES	  
d.	  Executive	  skills,	  such	  as	  planning,	  organizing	   NO	   YES	  
e.	  Getting	  disoriented,	  such	  as	  not	  knowing	  the	  date	  or	  
where	  you	  are	  
NO	   YES	  
If	  YES,	  have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
	  









6.	  Apart	  from	  the	  challenges	  listed	  above,	  TSC	  can	  have	  a	  big	  impact	  on	  
people’s	  lives	  in	  other	  ways.	  Have	  you/your	  child/family	  had	  any	  difficulties	  
with:	  
	  
a.	  Low	  self-­‐esteem	   NO	   YES	  
b.	  Very	  high	  levels	  of	  stress	  between	  parents	  leading	  to	  
significant	  relationship	  difficulties	  
NO	   YES	  
c.	  Very	  high	  levels	  of	  stress	  in	  families	   NO	   YES	  
If	  YES,	  have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
	  










7.	  Taking	  together	  all	  the	  difficulties	  discussed	  above,	  how	  much	  have	  these	  
bothered,	  troubled	  or	  distressed	  you/your	  child/family?	  	  
	  
0	  	  	  	  	  	  	  1	  	  	  	  	  2	  	  	  	  3	  	  	  	  4	  	  	  	  	  5	  	  	  	  	  6	  	  	  	  	  7	  	  	  	  	  8	  	  	  	  	  9	  	  	  	  	  10	  
Not	  at	  all	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Extremely	  	  
	  
	  
8.	  Interviewer’s	  judgement	  of	  impact/burden	  on	  the	  person/child/family.	  	  
	  
0	  	  	  	  	  	  	  1	  	  	  	  	  2	  	  	  	  3	  	  	  	  4	  	  	  	  	  5	  	  	  	  	  6	  	  	  	  	  7	  	  	  	  	  8	  	  	  	  	  9	  	  	  	  	  10	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Not	  at	  all	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Extremely	  
	  







10.	  Do	  you	  have	  any	  other	  worries	  about	  TAND	  that	  we	  
have	  not	  talked	  about	  as	  we	  went	  through	  the	  
checklist?	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Appendix B: TAND Checklist v.2 
	  
The	  TAND	  Research	  Checklist	  (2013)	  
Lifetime	  version	  (TAND-­‐CL)	  
	  
Tuberous	  Sclerosis	  Complex	  (TSC)	  is	  associated	  with	  a	  range	  of	  neuropsychiatric	  
disorders	  which	  we	  refer	  to	  as	  TAND	  (TSC-­‐Associated	  Neuropsychiatric	  Disorders).	  
All	  people	  with	  TSC	  are	  at	  risk	  to	  have	  some	  of	  these	  difficulties.	  Some	  people	  with	  
TSC	  have	  very	  few	  of	  these	  issues,	  while	  others	  will	  have	  many	  of	  these	  difficulties.	  
Each	  person	  with	  TSC	  will	  therefore	  have	  their	  own	  TAND	  profile,	  and	  this	  profile	  
may	  change	  over	  time.	  This	  checklist	  was	  developed	  to	  help	  clinical	  teams	  and	  
families	  a)	  screen	  for	  TAND	  at	  every	  clinic	  visit	  and	  b)	  prioritize	  with	  families	  what	  
to	  do	  next.	  
	  
Instructions	  to	  use	  the	  checklist.	  
The	  TAND	  checklist	  was	  designed	  to	  be	  completed	  by	  a	  clinician	  with	  relevant	  
knowledge	  and	  experience	  in	  TSC	  in	  partnership	  with	  parents	  or	  carers	  of	  
individuals	  with	  TSC.	  The	  checklist	  should	  take	  about	  10	  minutes	  to	  complete.	  
Where	  individuals	  answer	  YES	  to	  an	  item,	  the	  clinician	  should	  explore	  the	  difficulty	  
in	  sufficient	  detail	  to	  help	  guide	  decisions	  about	  further	  evaluation	  or	  treatment.	  
	  
All	  items	  should	  be	  completed.	  
	  
	  
Study	  Code	  of	  Participant:	  	   ………………..	  	  	  Date	  of	  interview:……/……/……	  
	  
Name	  of	  Interviewer:	   	   ……………………………………….	  
	  
Interviewee:	  Parent/Other:	  	   ……………………………………….	  
	  
________________________________________________________________________________________________	  
As	  you	  will	  know,	  the	  majority	  of	  people	  with	  TSC	  have	  some	  difficulty	  in	  
learning,	  behaviour,	  mental	  health,	  specific	  aspects	  of	  their	  development	  and	  
so	  on.	  We	  are	  going	  to	  use	  this	  checklist	  to	  help	  us	  check	  for	  these	  kinds	  of	  
difficulties.	  I	  am	  going	  to	  ask	  a	  number	  of	  questions.	  Some	  may	  be	  directly	  
relevant;	  some	  might	  not	  be	  at	  all.	  Just	  answer	  as	  best	  as	  you	  can.	  At	  the	  end	  I	  
will	  check	  to	  see	  if	  there	  are	  any	  additional	  difficulties	  we	  didn’t	  talk	  about.	  
	  
	  
1.	  Let’s	  begin	  by	  talking	  about	  your	  child’s	  development	  to	  get	  a	  sense	  of	  where	  
they	  are	  at.	  	  
	  
a.	  How	  old	  was	  ………	  when	  he/she	  first	  smiled?	   …weeks	   Not	  yet	  	  
b.	  Sat	  without	  support?	   …months	   Not	  yet	  
c.	  Walk	  without	  holding	  on?	   …months	   Not	  yet	  
d.	  Used	  single	  words	  other	  than	  “mamma”	  or	  “dadda”?	   …months	   Not	  yet	  
e.	  Used	  two	  words/short	  phrases?	   …months	   Not	  yet	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f.	  Toilet	  trained	  during	  the	  day?	   …years	   Not	  yet	  
g.	  Toilet	  trained	  at	  night?	   …years	   Not	  yet	  
	  
2.	  What	  is	  ………….	  current	  level	  of:	  (circle)	  	  
	  
	  
a.	  language:	  	  	  	  	  	  	  	  nonverbal	  	  	  	  	  	  	  	  	  	  	  	  -­‐	  	  	  	  	  	  	  	  	  	  simple	  language	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  -­‐	  	  	  	  	  	  	  	  	  	  	  	  	  	  fluent	  
	  
	  
b.	  self-­‐care:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  dependent	  on	  others	  	  	  	  -­‐	  	  	  	  	  	  	  some	  self-­‐care	  skills	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  independent	  
	  
	  
c.	  mobility:	  	  	  	  	  	  	  	  	  wheelchair	  	  	  	  -­‐	  	  	  	  needs	  significant	  support	  	  	  	  	  -­‐	  	  	  	  some	  difficulty	  	  	  	  	  -­‐	  	  	  	  	  	  
	  




3.	  Next	  we	  will	  talk	  about	  behaviours	  causing	  concern	  to	  you	  or	  to	  other	  
people.	  
Has	  […………]	  ever	  had	  difficulty	  with	  any	  of	  the	  following?:	  
	  
a.	  Anxiety	   NO	   YES	  
b.	  Depressed	  mood	   NO	   YES	  
c.	  Extreme	  shyness	   NO	   YES	  
d.	  Mood	  swings	   NO	   YES	  
e.	  Aggressive	  outbursts	   NO	   YES	  
f.	  Temper	  Tantrums	   NO	   YES	  
g.	  Self-­‐injury	  such	  as	  hitting,	  biting,	  scratching	  self	   NO	   YES	  
h.	  Absent	  or	  delayed	  onset	  of	  language	  to	  communicate	   NO	   YES	  
i.	  Repeating	  words	  or	  phrases	  over	  and	  over	  again	   NO	   YES	  
j.	  Poor	  eye	  contact	   NO	   YES	  
k.	  Difficulties	  getting	  on	  with	  other	  people	  of	  similar	  age	   NO	   YES	  
l.	  Repetitive	  behaviours	  such	  as	  doing	  the	  same	  thing	  over	  and	  over	  
again	  
NO	   YES	  
m.	  Very	  rigid	  or	  inflexible	  about	  how	  to	  do	  things	  and	  not	  liking	  
change	  in	  routines	  
NO	   YES	  
n.	  Overactivity/hyperactivity	   NO	   YES	  
o.	  Difficulty	  paying	  attention	  or	  concentrating	   NO	   YES	  
p.	  Restlessness,	  fidgetiness	   NO	   YES	  
q.	  Impulsivity	  such	  as	  butting	  in,	  not	  waiting	  turn	   NO	   YES	  
r.	  Difficulties	  with	  eating	  (too	  much,	  too	  little,	  unusual	  things)	   NO	   YES	  
s.	  Sleep	  difficulties	  such	  as	  with	  falling	  asleep	  or	  waking	  in	  the	  
night	  
NO	   YES	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If	  you	  answered	  YES	  to	  any	  of	  the	  above:	  
	  
Have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
	  















4.	  Problem	  behaviours	  may	  add	  up	  to	  meet	  criteria	  for	  specific	  psychiatric	  
disorders.	  Has	  your	  child/family	  member	  received	  a	  diagnosis	  of:	  
	  
a.	  Autism	  Spectrum	  Disorder	  (ASD),	  including	  autism,	  
asperger’s	  etc.	  
NO	   YES	  
b.	  Attention	  Deficit	  Hyperactivity	  Disorder	  (ADHD)	   NO	   YES	  
c.	  Anxiety	  Disorder	   NO	   YES	  
d.	  Depressive	  Disorder	   NO	   YES	  
e.	  Obsessive	  Compulsive	  Disorder	  (OCD)	   NO	   YES	  
f.	  Psychotic	  Disorder	  	   NO	   YES	  
	  
If	  you	  answered	  YES	  to	  any	  of	  the	  above,	  have	  you	  had	  further	  
evaluation	  or	  support	  for	  it?	  
	  













5.	  About	  half	  of	  people	  with	  TSC	  will	  have	  significant	  
difficulties	  in	  their	  overall	  intellectual	  development	  and	  
may	  have	  ‘intellectual	  disability’.	  Have	  you	  ever	  been	  











If	  YES,	  have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
	  










What	  is	  your	  view	  of	  your	  child’s/your	  family	  member’s	  intellectual	  ability?	  (circle)	  
	  
	  	  	  Normal	  Intellectual	  Ability	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  -­‐	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Mild	  or	  Moderate	  
Intellectual	  Disability	  
	  




6.	  Many	  people	  with	  TSC	  who	  are	  of	  school	  age	  will	  have	  difficulty	  in	  school.	  	  
[For	  individuals	  of	  school	  age]:	  	  	  	  	  	  	  	  Does	  ……..	  have	  any	  difficulty	  with	  one	  of	  the	  
following:	  
	  
	   96	  
[For	  individuals	  after	  school	  age]:	  	  	  Did	  ……….	  have	  any	  difficulty	  with	  one	  of	  the	  
following:	  
	  
a.	  Reading	   NO	   YES	  
b.	  Writing	   NO	   YES	  
c.	  Spelling	   NO	   YES	  
d.	  Mathematics	   NO	   YES	  
	  
If	  YES,	  have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
Has	  ………	  been	  considered	  for	  any	  additional	  support	  in	  school	  
such	  as	  extra	  help	  or	  an	  Individual	  Educational	  Plan	  (IEP)?	  
	  















7.	  The	  majority	  of	  people	  with	  TSC	  will	  have	  some	  difficulties	  in	  some	  specific	  
brain	  skills.	  Does	  your	  child/family	  member	  have	  difficulty	  with	  any	  of	  the	  
following	  brain	  skills:	  
	  
a.	  Memory,	  such	  as	  remembering	  things	  that	  have	  happened	   NO	   YES	  
b.	  Attention,	  such	  as	  concentrating	  well,	  not	  getting	  distracted	   NO	   YES	  
c.	  Dual-­‐tasking/	  Multi-­‐tasking	   NO	   YES	  
d.	  Visuo-­‐spatial	  tasks,	  such	  as	  puzzles	  and	  building	  blocks	   NO	   YES	  
e.	  Executive	  skills,	  such	  as	  planning,	  organizing	   NO	   YES	  
f.	  Getting	  disoriented,	  such	  as	  not	  knowing	  the	  date	  or	  where	  
you	  are	  
NO	   YES	  
	  
If	  YES,	  have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
	  










8.	  Apart	  from	  the	  challenges	  listed	  above,	  TSC	  can	  have	  a	  big	  impact	  on	  
people’s	  lives	  in	  other	  ways.	  Has	  your	  child/family	  had	  any	  difficulties	  with:	  
	  
a.	  Low	  self-­‐esteem	   NO	   YES	  
b.	  Very	  high	  levels	  of	  stress	  between	  parents	  leading	  to	  
significant	  relationship	  difficulties	  
NO	   YES	  
c.	  Very	  high	  levels	  of	  stress	  in	  families	   NO	   YES	  
	  
If	  YES,	  have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
	  











9.	  Taking	  together	  all	  the	  difficulties	  discussed	  above,	  how	  much	  have	  these	  
bothered,	  troubled	  or	  distressed	  your	  child/family?	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0	  	  	  	  	  	  	  1	  	  	  	  	  2	  	  	  	  3	  	  	  	  4	  	  	  	  	  5	  	  	  	  	  6	  	  	  	  	  7	  	  	  	  	  8	  	  	  	  	  9	  	  	  	  	  10	  
Not	  at	  all	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Extremely	  	  
	  
	  
10.	  Interviewer’s	  judgement	  of	  impact/burden	  on	  the	  child/family.	  	  
	  
	  
0	  	  	  	  	  	  	  1	  	  	  	  	  2	  	  	  	  3	  	  	  	  4	  	  	  	  	  5	  	  	  	  	  6	  	  	  	  	  7	  	  	  	  	  8	  	  	  	  	  9	  	  	  	  	  10	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Not	  at	  all	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Extremely	  
	  
	  












12.	  Do	  you	  have	  any	  other	  worries	  about	  TAND	  that	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Appendix C: TAND Checklist v3 
	  
The	  TAND	  Research	  Checklist	  (2013)	  
Lifetime	  version	  (TAND-­‐CL)	  
	  
	  
Tuberous	  Sclerosis	  Complex	  (TSC)	  is	  associated	  with	  a	  range	  of	  neuropsychiatric	  
disorders	  which	  we	  refer	  to	  as	  TAND	  (TSC-­‐Associated	  Neuropsychiatric	  Disorders).	  
All	  people	  with	  TSC	  are	  at	  risk	  to	  have	  some	  of	  these	  difficulties.	  Some	  people	  with	  
TSC	  have	  very	  few	  of	  these	  issues,	  while	  others	  will	  have	  many	  of	  these	  difficulties.	  
Each	  person	  with	  TSC	  will	  therefore	  have	  their	  own	  TAND	  profile,	  and	  this	  profile	  
may	  change	  over	  time.	  This	  checklist	  was	  developed	  to	  help	  clinical	  teams	  and	  
families	  a)	  screen	  for	  TAND	  at	  every	  clinic	  visit	  and	  b)	  prioritize	  with	  families	  what	  
to	  do	  next.	  
	  
Instructions	  to	  use	  the	  Checklist.	  
The	  TAND	  Checklist	  was	  designed	  to	  be	  completed	  by	  a	  clinician	  with	  relevant	  
knowledge	  and	  experience	  in	  TSC	  in	  partnership	  with	  parents	  or	  carers	  of	  
individuals	  with	  TSC.	  The	  Checklist	  should	  take	  about	  10	  minutes	  to	  complete.	  
Where	  individuals	  answer	  YES	  to	  an	  item,	  the	  clinician	  should	  explore	  the	  difficulty	  
in	  sufficient	  detail	  to	  help	  guide	  decisions	  about	  further	  evaluation	  or	  treatment.	  All	  
items	  should	  be	  completed.	  
	  
	  
TSC	  Patient:	  	  	   	   	  	  	  	  	  	  	  	  	  ………………………………….......	   	  	  	  	  	  	  	  	  	  DOB:	  	  	  
……/……/…….	  	   	  	  Age:	  	  …....	  
	  
Name	  of	  Interviewer:	   	  	  	  	  	  	  	  	  	  ……………………………………….	   	  	  	  	  	  	  	  	  	  Date	  of	  
interview:	  	  ……/……/……	  
	  




As	  you	  will	  know,	  the	  majority	  of	  people	  with	  TSC	  have	  some	  difficulty	  in	  
learning,	  behaviour,	  mental	  health,	  specific	  aspects	  of	  their	  development	  and	  
so	  on.	  We	  are	  going	  to	  use	  this	  checklist	  to	  help	  us	  check	  for	  these	  kinds	  of	  
difficulties.	  I	  am	  going	  to	  ask	  a	  number	  of	  questions.	  Some	  may	  be	  directly	  
relevant;	  some	  might	  not	  be	  at	  all.	  Just	  answer	  as	  best	  as	  you	  can.	  At	  the	  end	  I	  
will	  check	  to	  see	  if	  there	  are	  any	  additional	  difficulties	  we	  didn’t	  talk	  about.	  
	  
	  
1.	  Let’s	  begin	  by	  talking	  about	  your	  child’s	  development	  to	  get	  a	  sense	  of	  where	  
they	  are	  at.	  	  
	  
a.	  How	  old	  was	  ………	  when	  he/she	  first	  smiled?	   	   Not	  yet	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b.	  Sat	  without	  support?	   	   Not	  yet	  
c.	  Walk	  without	  holding	  on?	   	   Not	  yet	  
d.	  Used	  single	  words	  other	  than	  “mamma”	  or	  “dadda”?	   	   Not	  yet	  
e.	  Used	  two	  words/short	  phrases?	   	   Not	  yet	  
f.	  Toilet	  trained	  during	  the	  day?	   	   Not	  yet	  
g.	  Toilet	  trained	  at	  night?	   	   Not	  yet	  
	  
2.	  What	  is	  ………….	  current	  level	  of:	  	  
	  
	  
a.	  language:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  nonverbal	  	  	  	  	  	  	  	  	  	  	  	  -­‐	  	  	  	  	  	  	  	  	  	  simple	  language	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  -­‐	  	  	  	  	  	  	  	  	  	  	  	  	  	  fluent	  
	  
	  
b.	  self-­‐care:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  dependent	  on	  others	  	  	  	  -­‐	  	  	  	  	  	  	  some	  self-­‐care	  skills	  	  	  	  	  	  	  	  	  	  	  	  -­‐	  	  	  	  	  	  	  	  	  independent	  
	  
	  




3.	  Next	  we	  will	  talk	  about	  behaviours	  causing	  concern	  to	  you	  or	  to	  other	  people.	  
Has	  […………]	  ever	  had	  difficulty	  with	  any	  of	  the	  following?:	  
	  
a.	  Anxiety	   NO	   YES	  
b.	  Depressed	  mood	   NO	   YES	  
c.	  Extreme	  shyness	   NO	   YES	  
d.	  Mood	  swings	   NO	   YES	  
e.	  Aggressive	  outbursts	   NO	   YES	  
f.	  Temper	  Tantrums	   NO	   YES	  
g.	  Self-­‐injury	  i.e.	  hitting	  self,	  biting	  self,	  scratching	  self	   NO	   YES	  
h.	  Absent	  or	  delayed	  onset	  of	  language	  to	  communicate	   NO	   YES	  
i.	  Repeating	  words	  or	  phrases	  over	  and	  over	  again	   NO	   YES	  
j.	  Poor	  eye	  contact	   NO	   YES	  
k.	  Difficulties	  getting	  on	  with	  other	  people	  of	  similar	  age	   NO	   YES	  
l.	  Repetitive	  behaviours	  i.e.	  doing	  the	  same	  thing	  over	  and	  over	  again	   NO	   YES	  
m.	  Very	  rigid	  or	  inflexible	  about	  how	  to	  do	  things	  or	  not	  liking	  
change	  in	  routines	  
NO	   YES	  
n.	  Overactivity/hyperactivity	  i.e.	  abnormally	  active	   NO	   YES	  
o.	  Difficulty	  paying	  attention	  or	  concentrating	   NO	   YES	  
p.	  Restlessness,	  fidgetiness	  i.e	  wriggle	  or	  squirm	   NO	   YES	  
q.	  Impulsivity	  i.e.	  butting	  in,	  not	  waiting	  turn	   NO	   YES	  
r.	  Difficulties	  with	  eating	  (too	  much,	  too	  little,	  unusual	  things)	   NO	   YES	  
s.	  Sleep	  difficulties	  i.e.	  falling	  asleep	  or	  waking	  in	  the	  night	   NO	   YES	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Have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
	  









4.	  Problem	  behaviours	  may	  add	  up	  to	  meet	  criteria	  for	  specific	  psychiatric	  
disorders.	  Has	  your	  child/family	  member	  received	  a	  diagnosis	  of:	  
	  
a.	  Autism	  Spectrum	  Disorder	  (ASD),	  including	  autism,	  asperger’s	  	   NO	   YES	  
b.	  Attention	  Deficit	  Hyperactivity	  Disorder	  (ADHD)	   NO	   YES	  
c.	  Anxiety	  Disorder	  i.e.	  panic,	  phobia,	  PTSD	  	   NO	   YES	  
d.	  Depressive	  Disorder	   NO	   YES	  
e.	  Obsessive	  Compulsive	  Disorder	   	   	  
f.	  Psychotic	  Disorder	  i.e.	  schizophrenia	   NO	   YES	  
	  
If	  you	  answered	  YES	  to	  any	  of	  the	  above,	  have	  you	  had	  further	  
evaluation	  or	  support	  for	  it?	  
	  













5.	  About	  half	  of	  people	  with	  TSC	  will	  have	  significant	  difficulties	  
in	  their	  overall	  intellectual	  development	  and	  may	  have	  
‘intellectual	  disability’.	  Have	  you	  ever	  been	  concerned	  about	  











If	  YES,	  have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
	  











What	  is	  your	  view	  of	  your	  child’s/your	  family	  member’s	  intellectual	  ability?	  (circle)	  
	  





6.	  Many	  people	  with	  TSC	  who	  are	  of	  school	  age	  will	  have	  difficulty	  in	  school.	  	  
[For	  individuals	  of	  school	  age]:	  	  	  	  	  	  	  	  Does	  ……..	  have	  any	  difficulty	  with	  one	  of	  the	  
following:	  
[For	  individuals	  after	  school	  age]:	  	  	  Did	  ……….	  have	  any	  difficulty	  with	  one	  of	  the	  
following:	  
	  
a.	  Reading	   N/A	   NO	   YES	  
b.	  Writing	   N/A	   NO	   YES	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c.	  Spelling	   N/A	   NO	   YES	  
d.	  Mathematics	   N/A	   NO	   YES	  
	  
If	  YES,	  have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
Has	  …	  been	  considered	  for	  any	  additional	  support	  in	  
school	  such	  as	  extra	  help	  or	  an	  Individual	  Educational	  
Plan	  (IEP)?	  
	  
Would	  you	  like	  to	  have	  further	  evaluation	  or	  support	  for	  
it?	  
	  













7.	  The	  majority	  of	  people	  with	  TSC	  will	  have	  some	  difficulties	  in	  some	  specific	  
brain	  skills.	  Does	  your	  child/family	  member	  have	  difficulty	  with	  any	  of	  the	  
following	  brain	  skills:	  
	  
a.	  Memory,	  such	  as	  remembering	  things	  that	  have	  happened	   NO	   YES	  
b.	  Attention,	  such	  as	  concentrating	  well,	  not	  getting	  distracted	   NO	   YES	  
c.	  Dual-­‐tasking/	  Multi-­‐tasking,	  such	  as	  doing	  2	  tasks	  at	  the	  same	  time	   NO	   YES	  
d.	  Visuo-­‐spatial	  tasks,	  such	  as	  puzzles	  and	  building	  blocks	   NO	   YES	  
e.	  Executive	  skills,	  such	  as	  planning,	  organizing,	  inhibition,	  inflexible	  
thinking	  
NO	   YES	  
f.	  Getting	  disoriented,	  such	  as	  not	  knowing	  the	  date	  or	  where	  you	  are	   NO	   YES	  
	  
If	  YES,	  have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
	  











8.	  Apart	  from	  the	  challenges	  listed	  above,	  TSC	  can	  have	  a	  big	  impact	  on	  people’s	  
lives	  in	  other	  ways.	  Has	  your	  child/family	  had	  any	  difficulties	  with:	  
	  
a.	  Low	  self-­‐esteem	   NO	   YES	  
b.	  Very	  high	  levels	  of	  stress	  in	  families	  i.e.	  siblings	   NO	   YES	  
c.	  Very	  high	  levels	  of	  stress	  between	  parents	  leading	  to	  significant	  
relationship	  difficulties	  
NO	   YES	  
	  
If	  YES,	  have	  you	  had	  further	  evaluation	  or	  support	  for	  it?	  
	  











9.	  Taking	  together	  all	  the	  difficulties	  discussed	  above,	  how	  much	  have	  these	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0	  	  	  	  	  	  	  1	  	  	  	  	  2	  	  	  	  3	  	  	  	  4	  	  	  	  	  5	  	  	  	  	  6	  	  	  	  	  7	  	  	  	  	  8	  	  	  	  	  9	  	  	  	  	  10	  
Not	  at	  all	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Extremely	  	  
	  
	  
10.	  Interviewer’s	  judgement	  of	  impact/burden	  on	  the	  child/family.	  	  
	  
	  
0	  	  	  	  	  	  	  1	  	  	  	  	  2	  	  	  	  3	  	  	  	  4	  	  	  	  	  5	  	  	  	  	  6	  	  	  	  	  7	  	  	  	  	  8	  	  	  	  	  9	  	  	  	  	  10	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Not	  at	  all	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Extremely	  
	  
	  











12.	  Do	  you	  have	  any	  other	  worries	  about	  TAND	  that	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Appendix D: Expert Feedback Form 
 
 
UNIVERSITY	  OF	  CAPE	  TOWN	  
DIVISION	  OF	  CHILD	  AND	  ADOLESCENT	  PSYCHIATRY	  
	  
	  
Pilot	  validation	  of	  the	  Tuberous	  Sclerosis	  Complex	  Associated	  
Neuropsychiatric	  Disorders	  (TAND)	  checklist	  as	  screening	  tool	  for	  
neuropsychiatric	  manifestations	  
	  
Expert	  Feedback	  Form	  
	  
Please	  circle	  the	  number	  that	  is	  most	  representative	  of	  your	  views.	  
 
1. Does	  the	  checklist	  cover	  the	  relevant	  range	  of	  neuropsychiatric	  features	  you	  
think	  is	  important	  in	  TSC?	  	  
1	   	   	   2	   	   	   3	   	   	   4	   	   5	  
Not	  at	  all	   	   	   	   	   	   	   	   Very	  much	  





2. Are	  the	  items	  clear	  and	  understandable?	  	  
1	   	   	   2	   	   	   3	   	   	   4	   	   5	  
Not	  at	  all	   	   	   	   	   	   	   	   Very	  much	  
Please	  indicate	  unclear	  items	  and	  how	  you	  would	  suggest	  improving	  them:	  
	  






3. Overall,	  how	  easy	  do	  you	  think	  the	  checklist	  will	  be	  to	  use?	  	  
1	   	   	   2	   	   	   3	   	   	   4	   	   5	  
Not	  at	  all	   	   	   	   	   	   	   	   Very	  much	  





4. How	  likely	  do	  you	  think	  clinicians	  are	  to	  use	  the	  checklist?	  	  
1	   	   	   2	   	   	   3	   	   	   4	   	   	  	  	  	  	  5	  
Not	  at	  all	   	   	   	   	   	   	   	   Very	  much	  





5. How	  likely	  is	  the	  checklist	  to	  encourage	  clinicians	  to	  pursue	  further	  
neuropsychiatric	  work-­‐up	  or	  referral	  to	  relevant	  specialists?	  	  
1	   	   	   2	   	   	   3	   	   	   4	   	   5	  
Not	  at	  all	   	   	   	   	   	   	   	   Very	  much	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Strengths and Difficulties Questionnaire
For each item, please mark the box for Not True, Somewhat True or Certainly True.  It would help us if you answered all items as
best you can even if you are not absolutely certain or the item seems daft!  Please give your answers on the basis of the child's
behaviour over the last six months.
Child's Name .............................................................................................. Male/Female
Date of Birth...........................................................
Considerate of other people's feelings □ □ □
Restless, overactive, cannot stay still for long □ □ □
Often complains of headaches, stomach-aches or sickness □ □ □
Shares readily with other children (treats, toys, pencils etc.) □ □ □
Often has temper tantrums or hot tempers □ □ □
Rather solitary, tends to play alone □ □ □
Generally obedient, usually does what adults request □ □ □
Many worries, often seems worried □ □ □
Helpful if someone is hurt, upset or feeling ill □ □ □
Constantly fidgeting or squirming □ □ □
Has at least one good friend □ □ □
Often fights with other children or bullies them □ □ □
Often unhappy, down-hearted or tearful □ □ □
Generally liked by other children □ □ □
Easily distracted, concentration wanders □ □ □
Nervous or clingy in new situations, easily loses confidence □ □ □
Kind to younger children □ □ □
Often lies or cheats □ □ □
Picked on or bullied by other children □ □ □
Often volunteers to help others (parents, teachers, other children) □ □ □
Thinks things out before acting □ □ □
Steals from home, school or elsewhere □ □ □
Gets on better with adults than with other children □ □ □
Many fears, easily scared □ □ □
Sees tasks through to the end, good attention span □ □ □
Do you have any other comments or concerns?













Overall, do you think that your child has difficulties in one or more of the following areas:






If you have answered "Yes", please answer the following questions about these difficulties:





















• Do the difficulties put a burden on you or the family as a whole?
Not
at all
Signature ...............................................................................              Date ........................................
Mother/Father/Other (please specify:)







  □   □   □
6-12
months
  □   □   □  □































  □  □  □  □
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Strengths and Difficulties Questionnaire
For each item, please mark the box for Not True, Somewhat True or Certainly True.  It would help us if you answered all items as
best you can even if you are not absolutely certain or the item seems daft!  Please give your answers on the basis of how things
have been for you over the last six months.
Your Name .............................................................................................. Male/Female
Date of Birth...........................................................
I try to be nice to other people.  I care about their feelings □ □ □
I am restless, I cannot stay still for long □ □ □
I get a lot of headaches, stomach-aches or sickness □ □ □
I usually share with others (food, games, pens etc.) □ □ □
I get very angry and often lose my temper □ □ □
I am usually on my own.  I generally play alone or keep to myself □ □ □
I usually do as I am told □ □ □
I worry a lot □ □ □
I am helpful if someone is hurt, upset or feeling ill □ □ □
I am constantly fidgeting or squirming □ □ □
I have one good friend or more □ □ □
I fight a lot.  I can make other people do what I want □ □ □
I am often unhappy, down-hearted or tearful □ □ □
Other people my age generally like me □ □ □
I am easily distracted, I find it difficult to concentrate □ □ □
I am nervous in new situations.  I easily lose confidence □ □ □
I am kind to younger children □ □ □
I am often accused of lying or cheating □ □ □
Other children or young people pick on me or bully me □ □ □
I often volunteer to help others (parents, teachers, children) □ □ □
I think before I do things □ □ □
I take things that are not mine from home, school or elsewhere □ □ □
I get on better with adults than with people my own age □ □ □
I have many fears, I am easily scared □ □ □








Please turn over - there are a few more questions on the other side
Do you have any other comments or concerns?
	  





Overall, do you think that you have difficulties in one or more of the following areas:






If you have answered "Yes", please answer the following questions about these difficulties:

































  □   □   □
6-12
months
  □   □   □  □































  □  □  □  □
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Appendix F: Social Communication Questionnaire 
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Appendix H: Wessex Rating Scale 
	  
	  
These items refer to the person you care for. For each question (A, B, C, D etc …), 
please enter the appropriate code in each box. 
	  
(Frequently	  =	  more	  than	  once	  a	  week)	  
	  
A)	  Wetting	  (nights)	  	   1	  =	  frequently	   	  2	  =	  occasionally	  	  	  	  	  3	  =	  never	  
	   	  
B)	  Soiling	  (nights)	  	   1	  =	  frequently	   	  2	  =	  occasionally	  	  	  	  	  3	  =	  never	  
C)	  Wetting	  (days)	   1	  =	  frequently	   	  2	  =	  occasionally	  	  	  	  	  3	  =	  never	  
D)	  Soiling	  (days)	   1	  =	  frequently	   	  2	  =	  occasionally	  	  	  	  	  3	  =	  never	  
E)	  Walk	  with	  help	   1	  =	  not	  at	  all	   	  2	  =	  not	  up	  stairs	  	  	  	  	  3	  =	  up	  stairs	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  and	  elsewhere	  
	  
(note:	  if	  this	  person	  walks	  by	  himself	  upstairs	  and	  elsewhere,	  please	  also	  code	  ‘3’	  
for	  ‘walk	  with	  help’)	  
 
F)	  Walk	  by	  himself	  	  	  	  1	  =	  not	  at	  all	   	  2	  =	  not	  up	  stairs	  	  3	  =	  up	  stairs	  and	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   	   	   	   elsewhere  
G)	  Feed	  himself	  	  	  	  	  	  	  	  	  1	  =	  not	  at	  all	   	  2	  =	  with	  help	  	  	  	  	  	  3	  =	  without	  help	  
H)	  Wash	  himself	  	  	  	  	  	  	  	  1	  =	  not	  at	  all	   	  2	  =	  with	  help	  	  	  	  	  	  3	  =	  without	  help	  
I)	  	  	  Dress	  himself	  	  	  	  	  	  	  	  1	  =	  not	  at	  all	   	  2	  =	  with	  help	  	  	  	  	  	  3	  =	  without	  help	  
	  
J)	  Vision	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  =	  blind	  or	  almost	  	  	  2	  =	  poor	  	  	  	  	  	  	  	  3	  =	  normal	   	   	  
K)	  Hearing	   	  	  	  	  	  	  	  	  	  1	  =	  deaf	  or	  almost	  	  	  	  	  2	  =	  poor	   	  	  	  	  	  3	  =	  normal	  
	  
L)	  Speech	   	  	  	  	  	  	  	  	  1	  =	  never	  a	  word	  	  	   	  	  	  	  	  2	  =	  odd	  words	  only	  
	   	   	  	  	  	  	  	  	  	  3	  =	  sentences	  and	  normal	  	  	  	  4	  =	  can	  talk	  but	  doesn’t  
 
	  
	   118	  
If	  this	  person	  talks	  in	  sentences,	  is	  his/her	  speech:	  
1	  =	  Difficult	  to	  understand	  even	  by	  acquaintances,	  impossible	  for	  strangers?	  
2	  =	  Easily	  understood	  for	  acquaintances,	  difficult	  for	  strangers?	  
3	  =	  Clear	  enough	  to	  be	  understood	  by	  anyone?	  
 
M)	  Reads	   1	  =	  nothing	   2	  =	  a	  little	   3	  =	  newspapers	  and/or	  books	  
N)	  Writes	   1	  =	  nothing	   2	  =	  a	  little	   3	  =	  own	  correspondence	  




















	   119	  
Appendix I: Demographic Information 
 
UNIVERSITY	  OF	  CAPE	  TOWN	  
















1. Rural	  (1)	  or	  Urban	  living	  (2)	   	   	   1	   	   2	  
	  
	  
2. Household	  income	  
	  
<	  R3000	   	   	   R3000-­‐R5000	   	   R5000-­‐R10	  000	  
	   	  
	  
R10	  000-­‐R15	  000	   	   R15	  000-­‐R20	  000	   	   R20	  000+	  
	  






3. Parental	  level	  of	  education	  
	  
<	  Grade	  7/St.5	   Grade	  8/St.6	   	   Grade	  9/St.7	   	   Grade	  10/St.8	  
	  






INDIVIDUAL	  WITH	  TSC	  
	  
	  
1. Gender:	  Male	  (1)	  or	  Female	  (2)	   	   	   1	   	   2	  
	  
	  
2. Age:	  …………………………..	  
	  
	  
3. Grade	  level:	  ……………….	  
	  
	  
4. Schooling	  Placement:	  
	  
	  
Mainstream	   Private	  School	   Special	  Education	   Home	  	  	  	  	  	  	  	  	  	  School	  
	  
	  
	   121	  
	  
5. Neurospychiatric	  diagnosis:	  
	  
	  






6. Clinical	  Complications:	  
	  
	  
CNS	  Features	   	   Dermatological	  Features	   	   Renal	  Lesions	  	  
	  




7. Current	  Medication:	  
	  
	  
Notes:……………………………………………………………………………………………………	  
